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A straightforward procedure for the preparation of ynones from potassium 
alkynyltrifluoroborate salts and acyl chlorides or anhydrides has been developed. The 
one-pot reaction is advantageous in that it does not require exclusion of air or water, is 
operationally simple, has broad substrate scope, and proceeds rapidly under mild 
conditions in the presence of a Lewis acid. 2,6-dimethoxy substituted anhydrides afford 
the corresponding mono-demethylated o-alkynoylphenol precursors of aurone and 
flavone natural product scaffolds in good yields. A variety of flavones were obtained via 
6-endo cyclization of o-alkynoylphenol intermediates in the presence of 
trifluoromethanesulfonic acid (TfOH). Cesium carbonate was discovered to promote the 
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1. INTRODUCTION  
 
1.1 GENERAL BACKGROUND 
 
Organic chemistry, put simply, is the study of carbon compounds. Carbon is a group 4A 
element which means that it has the ability to share four valence electrons and form four 
strong covalent bonds.  Carbon atoms are particularly special as a result of their ability to 
bond to one another, allowing for the formation of long chains and rings. The diversity 
and quantity of known carbon-based compounds is staggering, ranging from simple 
single-carbon methane to extremely complex DNA which can have upwards of 100 million 
carbon atoms.  
Traditionally, the term organic chemistry has been associated with the study of 
compounds derived from living organisms. Modern chemistry, however, has made 
possible the design and synthesis of novel organic compounds in the laboratory. Synthetic 
organic compounds such as dyes, polymers, and pharmaceuticals have been designed for 
a variety of practical applications. Due to the extreme diversity of organic compounds, 
chemists are always seeking new tools for the manipulation of carbon compounds and 
the formation of new carbon-carbon bonds. Traditional methods for the formation of new 
carbon-carbon bonds are often associated with limitations such as inadequate functional 
group tolerance, poor atom economy, the need for harsh reaction conditions, and the use 
of toxic or costly reagents.  
The focus of this project has been the development and optimization of a novel, 
convenient methodology for the formation of an important class of organic functional 
group, specifically the ynone. The new method for the preparation of this valuable type 
of carbon-carbon bond has a number of advantages over traditional methods including 
good functional group tolerance and operational simplicity. This method has been applied 
toward the synthesis of a library of biologically relevant aurone and flavone natural 





1.2.1 UTILITY OF YNONES AS SYNTHETIC BUILDING BLOCKS 
 
Ynones are characterized by a ketone functional group with a carbon-carbon triple bond 
alpha to the carbonyl carbon. Ynones are valuable building blocks that have been applied 
toward the synthesis of a number of biomedically significant natural and unnatural 
products.[1] As illustrated by Scheme 1, ynones are precursors to a number of useful 
organic functional groups including pyrimidines,[2] quinolines,[3] furans,[4] pyrazoles,[5] 
oximes,[6] and chiral propargylic alcohols.[7] Additionally, ortho-hydroxyl substituted 
ynones are intermediates in the synthesis of aurone and flavone natural product scaffolds. 
These functional groups are of particular interest and will be discussed in detail in section 
1.4 Natural products. 
 
Scheme 1: Ynones are precursors to a variety of valuable organic scaffolds  
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Pyrimidines are a class of heterocycles widely recognised to have pharmacological 
activity.[8] Gleevec is an example of an FDA approved pharmaceutical for the treatment of 
several cancers which contains a pyrimidine scaffold.[9] The straightforward preparation 
of pyrimidines in modest to excellent yields from TMS-ynones is possible by addition of 
amidinium or guanidinium salts with sodium carbonate (Scheme 2).[2] 
 
Scheme 2: Preparation of pyrimidines from TMS-ynones 
 
Quinoline scaffolds are important substructures found in natural and designed 
compounds with valuable pharmacological activities.[10] Quinoline functionalities are 
prevalent in a variety of compounds with antibacterial and antimicrobial activities.[11] 
Specifically, quinoline-containing drugs are used in the treatment of malaria[12] and 
tuberculosis (Figure 1)[13]. Quinoline derivatives have also found application in materials 
science as ligands,[14] chemosensors for fluoride ions,[15] and as fluorescent sensors for 
selective metal ion recognition in aqueous solution.[16]  
 
Figure 1: Examples of FDA approved quinoline-containing drugs indicated for 
the treatment of malaria and tuberculosis. 
 
Quinolines may be prepared via cyclization of ortho-aminophenyl substituted ynones 




Scheme 3: Cyclization of o-aminophenyl ynones under basic conditions 
 
It is possible to obtain functionalized 2,4-disubstituted quinolines from ynone starting 
materials through tandem nucleophilic addition/annulation reactions (Scheme 4).[3b] 
 
Scheme 4: Preparation of functionalized 2,4-disubstituted quinolines through 
tandem nucleophilic addition/annulation reactions.  
 
Organoboron derivatives may also be applied towards the preparation of more interesting 
2,4-disubstituted quinolines from ynones (Scheme 5).[3a] 
 
Scheme 5: Preparation of 4-arylsubstituted quinolines with organoboron 
derivatives. 
 
Furan scaffolds have broad applicability in the production of conjugated polymers with 
desirable optical and electronic properties for applications such as solar cells, electronics, 
and biological devices.[18] 2,5-disubstituted furan derivatives have been synthesized from 
ynones with a methylene unit adjacent to the triple bond (Scheme 6).[4b] Polycyclic furans 
may be formed by heating conjugated ynones in the presence of a radical inhibitor to 
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promote intramolecular cycloaddition and subsequent rearrangement to a furan  
(Scheme 7).[4a] 
 
Scheme 6: Zinc promoted ynone cyclization to form 2,5-disubstituted furans. 
 
 
Scheme 7: Intramolecular [4+2] cyclization of conjugated ynones to form 
polycyclic furans.  
 
Substituted pyrazole derivatives are known to possess valuable biological activities 
including antimicrobial,[19] anti-inflammatory,[20] and anti-cancer properties.[21] 
Straightforward synthesis of pyrazoles from ynone precursors may be achieved by 
exposing them to hydrazine (Scheme 8).[5] 
 
Scheme 8: Straightforward preparation of substituted pyrazoles from ynone 
precursors. 
 
O-methyl oximes are valuable intermediates toward the synthesis of isoxazoles. 
Substituted isoxazoles have been shown to have a range of bioactivities including 
anticancer,[22] analgesic,[23] anti-inflammatory,[23] and antinociceptive[24] characteristics. 
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O-methyl oximes are readily prepared by stirring an ynone in the presence of 
methoxylamine hydrochloride, pyridine and sodium or magnesium sulfate.[6a] 3,5-
disubstituted isoxazoles may be prepared by palladium catalyzed cyclization of O-methyl 
oximes (Scheme 9).[6a] Isoxazoles may be further substituted in the 4-position by 
performing the cyclization in the presence of an electrophile such as iodine monochloride 
to form the corresponding 4-iodoisoxazole. Submission of 4-iodoisoxazole to palladium-
catalyzed reactions can yield a variety of 3,4,5-trisubstituted isoxazoles.[6b]  
 
Scheme 9: Conversion of ynones to isoxazoles via O-methyl oxime 
intermediates 
 
Chiral propargylic alcohols are valuable intermediates for the enantioselective 
preparation of complex structures of structural and biological interest such as steroids,[25] 
alkaloids,[26] macrolides,[27] and enediyne antibiotics[28] to name just a few examples. The 
selective reduction of ynones to propargylic alcohols with high enantiomeric purity may 
be achieved by transfer hydrogenation using chiral Ru(II) catalysts and isopropanol as the 
hydrogen donor (Scheme 10).[7c] Alternatively, propargylic alcohols may be obtained with 
high enantiomeric purity through catalytic enantioselective reduction of ynones with a 
chiral oxazaborolidine and catecholborane.[7a] 
 





1.2.2 PREPARATION OF YNONES 
 
Given their function as building blocks for a variety of useful organic scaffolds, there are a 
number of methods in the literature for the preparation of ynones. Ynones are commonly 
prepared by reacting acyl chlorides with metal[29] or metalloid[30] acetylides (Scheme 11).  
 
Scheme 11: Preparation of ynones from acyl chlorides and metal or metalloid 
acetylides. 
 
Alternatively, ynones may be prepared in two-step procedures by converting acyl 
chlorides to N-methoxy-N-methylamides (known as Weinreb amides) and reacting them 
with alkynyllithium or Grignard reagents (Scheme 12).[31]  
 
Scheme 12: Preparation of ynones using Weinreb amides and alkynylmetallic 
reagents. 
 
Ynones may also be formed by addition of an alkynylmetallic reagent to an aldehyde, 
followed by oxidation of the resulting secondary alcohol to the corresponding ketone 






Scheme 13: Preparation of ynones by addition of alkynylmetallic reagents to 
aldehydes followed by oxidation. 
 
The metal acetylides employed in several of the aforementioned methods for ynone 
preparation are associated with poor functional group tolerance thus limiting their 
substrate scope and utility. Additionally, multi-step procedures that require purification 
of reaction intermediates are inconvenient and result in reduced yields. 
Transition-metal-catalyzed carbonylative Sonogashira couplings are another more recent 
method that has emerged for the preparation of ynones (Scheme 14).[33] Unfortunately, 
transition metal-catalyzed reactions often require elevated pressures of carbon monoxide 
and result in formation of unwanted direct coupling byproduct. In addition to these 
undesirable features, transition metal catalysts are costly and toxic. 
 
Scheme 14: Preparation of ynones by carbonylative Sonogashira coupling of 
terminal alkynes with aryl halides.  
 
Clearly, given their utility as synthetic building blocks, a more straightforward method for 
the preparation of ynones is desirable.  
 
1.2.3 PREPARATION OF O-ALKYNOYLPHENOLS 
 
O-Alkynoylphenol compounds (Figure 2) are a class of ortho-hydroxyaryl substituted 
ynones that are of particular synthetic interest. A convenient method for the preparation 
of functionalized o-alkynoylphenols is appealing because these compounds are synthetic 
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intermediates in the preparation of aurone and flavone natural product derivatives.[34] 
Many of the aforementioned synthetic methods for the preparation of ynones are poorly 
suited to the preparation of sterically hindered ynones including o-alkynoylphenols. This 
section details the methods that have been employed for the preparation of o-
alkynoylphenols including the sterically hindered examples that have been reported.  
 
Figure 2: General structure of a sterically hindered o-alkynoylphenol 
 
 
Scheme 15: Preparation of substituted o-alkynoylphenol by carbonylative 
Negishi coupling 
 
Sterically bulky ynones have been prepared by carbonylative cross-coupling of 2,6-
dimethyliodobenzene with alkynylboronic esters or alkynylzinc reagents.[35] Electron-rich 
2-iodo-3,5-dimethylanisole proved to be a more challenging substrate, resulting in 
formation of unwanted direct-coupling byproduct. Recently, carbonylative Negishi 
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coupling of an alkynylzinc reagent with electron-rich 2,4,6-trimethoxyiodobenzene has 
been demonstrated in modest yield (Scheme 15).[36] Selective monodemethylation of 
ortho-hydroxy group is a challenge. 
Protected o-alkynoylphenol acetates have been prepared via Sonogashira coupling of acyl 
chlorides with terminal alkynes (Scheme 16).[37] No sterically hindered examples have 
been reported by this method. Due to the limited availability of substituted benzoyl 
chloride derivatives, it is necessary to prepare the acyl chloride from the corresponding 
benzoic acid in situ using oxalyl chloride.  
Scheme 16: Preparation of protected o-alkynoylphenol by Sonogashira coupling of acyl 
chloride with terminal alkyne. 
 
Hindered o-alkynoylphenol has been prepared by reacting a substituted phenol and 2-
butynoic acid in Eaton’s reagent[38] (10% phosphorus pentoxide in methanesulfonic acid) 
in 68% yield (Scheme 17).[39] Unfortunately, this method is very limited since examples of 
this particular reaction that do not employ a penta-substituted starting material result in 
a mixture of several products. 
 
Scheme 17: Preparation of sterically bulky o-alkynoylphenol using Eaton’s 
reagent. 
 
Di-ortho substituted o-alkynoylphenol compounds have been prepared by adding a 
lithium acetylide to an aldehyde and subsequently oxidizing the secondary alcohol to the 
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corresponding ketone (Scheme 18).[34f, 34g] Yields of hindered ynones prepared by this 
method are quite poor and, as previously mentioned, this method is not preferable due 
to the limited substrate scope of metal acetylides. 
 
Scheme 18: Preparation of sterically bulky o-alkynoylphenol by addition of a 
lithium acetylide to an aldehyde followed by oxidation.  
 
1.3 POTASSIUM ORGANOTRIFLUOROBORATE SALTS 
 
Our laboratory is interested in transition-metal-free reactions of organoboranes. In 
particular, potassium organotrifluoroborate salts have recently gained momentum as 
versatile reagents in organic synthesis. Organotrifluoroborate salts are appealing reagents 
as a result of their straightforward preparation, low toxicity, and inherent stability.[40] 
Traditionally, organotrifluoroborate salts have been a convenient alternative to unstable 
boronic acids for palladium-catalyzed Suzuki-Miyaura coupling.[41]  
 
1.3.1 NON-METAL-CATALYZED REACTIONS OF POTASSIUM 
ORGANOTRIFLUOROBORATE SALTS 
 
Although potassium organotrifluoroborate compounds are well known for their utility in 
transition metal catalyzed reactions, trifluoroborates have recently emerged as attractive 
reagents in mild, transition-metal-free reactions.[42] 
 
1.3.1.1 Lewis acid catalyzed reactions 
 
In 2002 Matteson demonstrated the value of organotrifluoroborate salts in non-metal-
catalyzed reactions with the preparation of asymmetric secondary amines via reaction of 
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alkyltrifluoroborates with azides (Scheme 19). Here, tetrachlorosilane was used as a 
defluoridating agent to form a reactive difluoroborane intermediate.[43] 
 
Scheme 19: Lewis acid catalyzed secondary amine preparation from potassium 
alkyltrifluoroborate and azide. 
 
Bode and coworkers have illustrated a straightforward approach for the preparation of 
unsymmetrical dialkyl ethers from aryl-, alkenyl, and alkynyltrifluoroborates and mixed 
acetals (Scheme 20). In this case boron trifluoride diethyletherate was used to strip a 
fluoride from the salt to form a Lewis acidic organodifluoroborane species.[44] More 
recently, the reaction has been improved through the use of a hydroxamate leaving group. 
This improved the regioselectivity of challenging substrates, reduced the need for a large 
excess of organotrifluoroborate and Lewis acid, and increased the yield of the ether 
formation allowing for the use of more challenging electron-withdrawing substrates.[45] 
 
Scheme 20: Lewis acid catalysed mixed ether formation from potassium 
organotrifluoroborate and acetal.  
 
Stefani and coworkers developed a mild and stereoselective method for α-C-glycosidation 
of D-glucal with a variety of potassium alkynyltrifluoroborates (Scheme 21).[46] Activation 
of the alkynyltrifluoroborate with boron trifluoride diethyletherate results in formation of 
a Lewis acidic difluoroborane species. The difluoroborane intermediate activates acetal 
protected D-glucal, generating an oxonium cation and a nucleophilic species that attacks 
from the α-side to regioselectively afford the α-anomer of the alkynyl C-glycoside. Boron 
trifluoride has also been used to promote the formation of C-glycosides from glycosyl 





Scheme 21: Lewis acid catalyzed preparation of α-C-glycosides 
 
1.3.1.2 Reactions with persistent carbenium ions 
 
DDQ has been demonstrated to promote oxidative carbon-hydrogen cleavage of 
chromenes to form persistent aromatic oxocarbenium ions. Reaction of these 
oxocarbenium intermediates with alkynyl, alkenyl, and phenylpotassium trifluoroborates 
affords the corresponding 2-substituted-2H-chromenes (Scheme 22).[48] In this case the 
trifluoroborate is acting as a nucleophilic species, attacking the reactive oxocarbenium 
ion.  
 
Scheme 22: Chromene functionalization via nucleophilic attack of potassium 
organotrifluoroborates on persistent aromatic oxocarbenium ion 
 
Benzodithiolylium tetrafluoroborate is a commercially available carbenium ionic 
compound that has been shown to undergo direct reaction with potassium 
(hetero)aryltrifluoroborates (Scheme 23).[49] 
 






1.3.1.3 Other metal-free reactions of organotrifluoroborates 
 
Acyltrifluoroborates have been used toward the straightforward preparation of amides 
from o-benzoyl hydroxylamines (Scheme 24).[50] In this case a fluorophile is not required 
to activate the trifluoroborate species. The mechanism of this particular reaction is 
unclear, however it likely proceeds via a hemiaminal intermediate which forms from 
attack of the hydroxylamine on the electrophilic carbonyl of the acyltrifluoroborate 
species.  
 
Scheme 24: Amide formation from Acyltrifluoroborates and hydroxylamines in 
water. 
 
Regioselective ring-opening of epoxides with potassium organotrifluoroborates has been 
demonstrated in the presence of trifluoroacetic anhydride (Scheme 25).[51] 
 
Scheme 25: Trifluoroacetic anhydride promoted stereospecific ring-opening of 
epoxides with potassium trifluoroborates 
 
1.4 NATURAL PRODUCTS: AURONES AND FLAVONES 
 
Aurones and flavones (Figure 3) are structurally isomeric classes of flavonoid natural 
products that are recognized as valuable organic scaffolds due to their biological 
activities.[52] Aurones are characterized by a 3-benzofuranone scaffold with a benzylidene 
moiety linked to the 2 position. Flavones are characterized by a 4-benzopyranone scaffold 
with a benzene ring at the 2 position. Structurally, these functional groups are quite 




Figure 3: Structures of substituted aurone and flavone scaffolds  
 
There are a wide variety of natural aurone and flavone derivatives as a result of the 
possibility for functionalization of either aromatic ring. A wide array of hydroxyl and 
methoxy-substituted flavones can be found in fruits, vegetables, flowers, and barks.[53] In 
particular, polymethoxyflavones (PMFs) are an interesting sub-class of flavones due to 
their biological activities including anti-inflammatory, anti-carcinogenic, and anti-
atherogenic properties.[53a, 54] Furthermore, increased metabolic stability of PMFs has 
been demonstrated in comparison to unmethylated polyhydroxyflavone analogues.[55] 
Potent anti-cancer activity of PMFs has recently been demonstrated.[56] Aurones are 
relatively limited in their natural abundance compared to flavones and as a result have 
been less extensively studied. Also found in some marine organisms, aurones are yellow 
dyes that contribute to the colouration of many fruits, vegetables, and flowers.[57] 
Aurones have been identified as phytoalexins, contributing to the defense mechanisms of 
plants against infections.[58] Additionally, functionalized aurones have been demonstrated 
as functional scaffolds for the modulation of proteins linked to multidrug resistance in 
cancer chemotherapy.[59] 
 
1.4.1 SYNTHESIS OF FLAVONES 
 
Flavone scaffolds are of particular synthetic interest as a result of the diversity of 
favourable biological activities that they exhibit. Consequently, a number of methods for 
the synthesis, transformation, and functionalization of flavones are available.[60]  
16 
 
Flavones are frequently prepared from β-diketone intermediate prepared using the base-
catalyzed Baker-Venkataraman rearrangement of 2-acetoxyacetophenones (Scheme 
26).[61] Harsh conditions such as treatment with concentrated sulfuric acid[62] or 
microwave irradiation[63] are required to promote cyclization of the diketone.  
 
Scheme 26: Flavone synthesis by cyclization of diketone formed by Baker-
Venkataraman rearrangement. 
 
An alternative method for the preparation of flavones involves the oxidative cyclization of 
substituted 2-hydroxy chalcones, which are prepared by an aldol condensation between 
an aldehyde and a 2-hydroxyacetophenone (Scheme 27).[64]  
Scheme 27: Flavone synthesis by oxidative cyclization of 2-hydroxy chalcones. 
 
Recently, the preparation of flavones has been achieved by palladium-catalyzed 




Scheme 28: Flavone synthesis by palladium catalyzed carbonylative coupling of 
terminal alkynes with aryl halides. 
 
1.4.2 SYNTHESIS OF AURONES 
 
Generally, the synthesis of aurones is achieved by one of two methods: oxidative 
cyclization of 2’-hydroxychalcones[66] or aluminum oxide catalyzed condensation of 
substituted benzaldehydes with benzofuranones.[67] Oxidative cyclization of 2’-
hydroxychalcones may be achieved in the presence of mercury acetate[66b] or thallium(III) 
trinitrate (TTN) (Scheme 29).[66c] 
 
Scheme 29: Oxidative cyclization of 2-hydroxy chalcones to form aurones. 
 
Aluminum oxide catalyzed preparation of aurone scaffolds from benzofuranone and 
benzaldehydes is straightforward (Scheme 30). This method becomes less trivial if the 
benzofuranone starting material is not commercially available since the preparation 
requires multiple steps.[67a, 67b] 
 




Another method for the production of aurones involves the gold(I) catalyzed cyclization 
of ortho-(1-hydroxyprop-2-ynyl)phenols and subsequent oxidation of the secondary 
alcohol to a ketone (Scheme 31).[68]  
 
Scheme 31: Aurone synthesis by gold chloride catalyzed cyclization of ortho-(1-
hydroxyprop-2-ynyl)phenols and subsequent oxidation.  
  
Aurones have also been prepared in good yields by palladium catalyzed carbonylative 
annulation of terminal alkynes and 2-bromophenols.[65b] Modification of the ligands 
employed in the palladium catalyzed reaction makes it is possible to favour the formation 
of aurone products over flavones. In all cases, however, a product mixture was recovered 
with 3-8% flavone product composition. 
 
1.4.3 CYCLIZATION OF O-ALKYNOYLPHENOLS 
 
In addition to the previously discussed methods, both aurone and flavone scaffolds may 
be obtained via cyclization of o-alkynoylphenol precursors (Scheme 32). Conventional 
methods for the preparation of aurones and flavones are associated with disadvantages 
such as onerous multi-step procedures, harsh reaction conditions, the need for transition 
metal catalysts, and relatively poor yields. As a result of these deficiencies, the cyclization 




Scheme 32: Cyclization of o-alkynoylphenols to form flavone and aurone 
scaffolds. 
 
Under basic conditions the 5-exo and 6-endo ring closure of o-alkynoylphenols are 
competing pathways.[34a, 34b, 34d] Basic conditions generally favour the 5-exo cyclization 
mode resulting in aurone products, however, this is largely dependent on the nature of 
the base and the conditions applied. The major product may be influenced by 
manipulation of the reaction conditions, however accounts in the literature indicate a 
mixture of both cyclization products.[34a, 34b, 34d] The 5-exo cyclized aurone product is 
primarily formed by silver (I) ion catalysis, however, trace amounts of the flavone product 
are also formed.[34c] Recently, the 5-exo cyclization of o-alkynoylphenols was also found 
to be favoured in tributylphosphine-catalyzed reactions.[34e] Unfortunately, separation of 
structurally similar aurone and flavone products is not trivial, and therefore methods 
resulting in a product mixture are not ideal.  
Application of the principles of the Morita-Baylis-Hillman reaction makes possible the 
regioselective 6-endo cyclization of o-alkynoylphenols.[69] Exclusive preparation of 
flavones from o-alkynoylphenol precursors may be achieved by 1,4-addition of a 
nucleophile to the β-carbon of the ynone system. Intramolecular Michael addition and 
subsequent elimination of the nucleophile results in the 6-endo cyclized flavone 
product.[34f, 34g, 70] Trifluoromethanesulfonic acid (TfOH) has been successfully employed 
to promote the exclusive 6-endo cyclization of o-alkynoylphenols to produce various 
flavone products using this strategy.[34f]  
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1.5 THESIS OBJECTIVE 
 
Section 1.3.1 highlighted the utility of organotrifluoroborate salts as nucleophiles in non-
metal-catalyzed reactions. In the presence of a Lewis acid, trifluoroborate salts are 
converted to a species with nucleophilic character, facilitating an attack towards an 
electrophilic species. 
Our goal was to develop a straightforward, metal-free procedure for the preparation of 
ynones. Much like traditional methods for ynone synthesis, our retrosynthetic approach 
was to make a disconnection between the carbonyl and the triple bond of the desired 
functional group (Scheme 33). In this case, however, we would avoid the use of alkynyl 
metallic nucleophiles. We hypothesized that, in the presence of a Lewis acid, an alkynyl 
trifluoroborate salt could react with an electrophilic carbonyl in order to form an ynone 
functional group.  
 
Scheme 33: Retrosynthetic analysis for the metal-free preparation of ynones 
 
The overall objective of this research is to explore the formation of new carbon-carbon 
bonds using potassium organotrifluoroborate salt starting materials. Specifically, the goal 
of this project is to develop and optimize a convenient method for the preparation of 
functionalized ynones and apply it towards the straightforward synthesis of a variety of 







2. EXPERIMENTAL METHODS 
 
2.1 GENERAL EXPERIMENTAL CONSIDERATIONS 
 
Unless otherwise noted, all reagents and materials were obtained from commercial 
suppliers and used without further purification. Reactions were carried out under air 
unless otherwise noted. NMR characterization data was obtained at 25 °C on an Oxford 
AS400 NMR spectrometer as solutions in deuterated solvents (CDCl3 and DMSO-d6 
obtained from Cambridge Isotope Laboratories, Inc.). 1H NMR spectra were recorded at 
400 MHz and referenced to the residual solvent peak at 7.24 ppm for CDCl3 and 2.50 ppm 
for DMSO-d6. 13C{1H} NMR spectra were recorded at 100MHz and referenced to the 
residual solvent peak at 77.00 ppm for CDCl3 and 39.51 ppm for DMSO-d6. 19F NMR spectra 
were collected at 400 MHz and referenced to the lock position. 11B NMR spectra were 
collected at 100 MHz and referenced to BF3·OEt2. FT-IR spectra were recorded on a Nicolet 
Avatar 370 DTGS spectrometer or a Bruker ALPHA spectrometer and only partial data are 
provided. High resolution mass spectra (HRMS) were obtained by the University of 
Michigan, Department of Chemistry. An Agilent Q-TOF mass spectrometer was used for 
samples analyzed by electrospray (ESI) and atmospheric-pressure chemical ionization 
(APCI) and a Waters VG 70-250-S magnetic sector mass spectrometer was used for 
samples analyzed by electron impact ionization (EI). Flash column chromatography on 
silica gel (60 Å, low acidity, obtained from EMD Chemicals Inc.) was performed using 
reagent grade solvents unless otherwise specified. Tetrahydrofuran (THF) and 
triethylamine (TEA) was purified using an Innovative Technology PS-MD-3 solvent 





2.2 PREPARATION OF POTASSIUM 
ALKYNYLTRIFLUOROBORATES 
 
Potassium alkynyltrifluoroborate salts were prepared from terminal alkynes according to 
a procedure modified from Stefani and coworkers.[46] 
 
 
General Procedure for the preparation of potassium alkynyltrifluoroborate salts: A 
solution of the indicated terminal alkyne (1.0 equiv.) in dry THF was cooled to -60 °C under 
argon atmosphere, n-BuLi (1.0 equiv.) was added dropwise and the solution was stirred 
for 1 h at this temperature. Trimethylborate (1.5 equiv.) was added dropwise at -30 °C.  
The solution was stirred at -30 °C for 1 h and allowed to warm to room temperature for 1 
h. A saturated aqueous solution of potassium hydrogen difluoride (6.0 equiv.) was added 
at -20 °C. The mixture was allowed to stir for 1 h at -20 °C followed by 1 h at room 
temperature. The solvent was removed, and the resulting solid was placed under vacuum 
for 2 h. The solid was washed several times with hot acetone which was decanted off and 
collected. The product was precipitated from acetone with diethyl ether and cooled to 4 
°C to complete precipitation. The crystalline solids were collected by suction filtration and 
dried under vacuum to afford trifluoroborate salts 1a-g (Figure 4). 
Figure 4: Alkynyltrifluoroborate salts used in this manuscript. 
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2.3 PREPARATION OF YNONES  
 
General Procedure for the synthesis of ynones from acyl chlorides and potassium 
alkynyltrifluoroborate salts: Boron trichloride (1M solution in DCM) was placed in a 2 mL 
vial containing a stir bar and a 0.2M solution of the indicated potassium 
alkynyltrifluoroborate salt in anhydrous DCM. The vial was capped, sonicated for 30 s, and 
stirred for 15 min at room temperature. The indicated acyl chloride was added dropwise 
to the vial, capped and stirred for 30 min. The reaction was quenched with cold water and 
extracted into ethyl acetate. The organic layer was washed twice with water and once 
with brine. The organic layer was dried over MgSO4 and concentrated. The product was 
purified by flash column chromatography using hexanes/ethyl acetate and concentrated 
to afford the ynone products 2a-m (Figure 5, p 30), 3a-c, 4a-c, 5a, 6a (Figure 7, p 33). 
 
2.4 PREPARATION OF MIXED ANHYDRIDES 
 
General Procedure for the preparation of mixed anhydrides from carboxylic acids and 
acetyl chloride: Triethylamine (2.0 equiv.) was added dropwise at ambient temperature 
to a 0.25M solution of the indicated benzoic acid (1.0 equiv.) in dry THF. The mixture was 
cooled to -10 °C and acetyl chloride (1.1 equiv.) was added dropwise. The mixture was 
stirred at room temperature for 6 hours, filtered, and evaporated. The crude product was 
filtered through a pad of silica with ethyl acetate to afford mixed anhydrides 7a (R = OMe) 
and 7b (R = H). 
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2.5 PREPARATION OF O-ALKYNOYLPHENOLS 
 
 
General procedure for the synthesis of o-alkynoylphenols from mixed anhydrides and 
potassium alkynyltrifluoroborate salts: Boron trichloride (1M in DCM, 3.0 equiv.) was 
added dropwise to the indicated alkynyltrifluoroborate salt (1.5 equiv.) in anhydrous DCM 
at room temperature under air. The capped reaction was sonicated for 30 s and stirred an 
additional 20 min. The selected anhydride (1.0 equiv.) was added to the reaction mixture 
in one lot, capped, and stirred at room temperature for 45 min. The reaction mixture was 
quenched with cold water and extracted into ethyl acetate. The organic layer was washed 
twice with water and once with brine. The organic layer was dried over MgSO4, filtered, 
and concentrated. The crude product was purified by flash chromatography to afford o-



















2.6 CYCLIZATION OF O-ALKYNOYLPHENOLS 
 
Flavones were prepared from o-alkynoylphenols according to a procedure modified 
from Doi and coworkers.[34f] 
 
General Procedure for the 6-endo cyclization of o-alkynoylphenols: TfOH (5.0 equiv.) was 
added dropwise to a 0.25M solution of the indicated o-alkynoylphenol in 1,2-
dichloroethane at 0 °C under argon. The mixture was stirred at 40oC and then quenched 
with saturated aqueous NaHCO3 at 0 °C. The organic layer was separated and the aqueous 
layer extracted twice with ethyl acetate. The combined organic layers were washed with 
brine, dried over MgSO4, and filtered. The filtrate was concentrated and the crude product 
was purified by flash chromatography on silica gel to afford flavone products 9a-e (Figure 
9, p 41). 
 
 
General Procedure for the 5-exo cyclization of o-alkynoylphenols: Cs2CO3 (3.0 equiv.) 
was added in one lot to a 0.1M solution of o-alkynoylphenol in acetone at ambient 
temperature under air. After 30 minutes the reaction was quenched with aqueous NH4Cl. 
The aqueous layer was extracted three times with ethyl acetate. The combined organic 
layers were washed with brine, dried over MgSO4, and filtered, and evaporated to afford 




3. PREPARATION OF YNONES FROM ACYL CHLORIDES 
AND POTASSIUM ALKYNYLTRIFLUOROBORATE SALTS 
 
3.1 OPTIMIZATION OF REACTION CONDITIONS 
 
Initially, we focused on the preparation of ynone 2a from benzoyl chloride and 
phenylacetylene trifluoroborate 1a. In order to find a suitable catalyst, several Lewis acids 
were screened (Table 1). Silica gel,[71] silicon tetrachloride,[41] and boron trifluoride[44-45] 
have been reported to convert organotrifluoroborates into organodihaloboranes. 
Unfortunately, these Lewis acids did not promote the formation of the desired ynone 
product (Table 1, entries 1-3). Product 2a was obtained in 24% yield when iron(III) chloride 
was employed (Table 1, entry 4). Aluminum(III) chloride is known to promote the 
formation of oxocarbenium ions in Friedel-Crafts acylation reactions.[72] Indeed, we 
obtained the desired ynone 2a in 62% yield in the presence of the aluminum trichloride 
catalyst under anhydrous conditions (Table 1, entry 5). 
Upon running the reaction under non-anhydrous conditions under air a similar was 
obtained (Table 1, entry 6). When a controlled quantity of water was added to the reaction 
the yield did not improve (Table 1, entry 7). Once it became apparent that the reaction 
can tolerate moisture, subsequent reactions (Table 1, entries 8-15) were performed under 
air in non-dried glassware. 
Next, attempts were made to optimize the solvent system. Aprotic solvents including THF, 
toluene, and dichloroethane as well as polar solvents such as DMSO and acetonitrile were 
tested with little success (Table 1, entries 8-12). The poor results of the solvent 






Table 1: Optimization of Conditions for the Preparation of Ynone 2aa. 
 
entry Lewis acid Lewis acid (equiv) solvent yield (%) 
1b SiO2 16.5 CH2Cl2 0 
2 SiCl4 1.0 CH2Cl2 trace 
3 BF3·OEt2 1.0 CH2Cl2 trace 
4b FeCl3 1.0 CH2Cl2 24 
5c AlCl3 1.0 CH2Cl2 62 
6d AlCl3 1.0 CH2Cl2 66 
7e AlCl3 1.0 CH2Cl2 60 
8 AlCl3 1.0 THF trace 
9 AlCl3 1.0 toluene trace 
10 AlCl3 2.0 ClCH2CH2Cl 33 
11 AlCl3 1.0 DMSO trace 
12 AlCl3 2.0 acetonitrile trace 
13 AlCl3·6H2O 1.0 CH2Cl2 0 
14b BCl3 1.5 CH2Cl2 67 
15 BBr3 1.0 CH2Cl2 20 
aReactions were run with 1 equiv benzoyl chloride and 1 equiv potassium phenylacetylenetrifluoroborate 
1a. b1.5  equiv 1a. canhydrous conditions. dthe reaction was done in non-dried glassware under air. 
eanhydrous conditions + 1 µL of water.  
 
Unfortunately, there were some issues with the reproducibility of the results of the 
aluminum chloride catalyzed reactions. Exposure to air can result in the formation of 
aluminum(III) chloride hydrate. We hypothesized that formation of the hydrate on the 
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surface of the catalyst was inhibiting the reaction. In order to test this hypothesis, 
commercially available aluminum(III) chloride hexahydrate was tested under the 
developed reaction conditions. As suspected, the hydrated form of the aluminum 
trichloride catalyst was inactive and no product formation was observed (Table 1, entry 
13). 
Therefore, we continued our search for a suitable catalyst. We were pleased to obtain 
product 2a in similar yields with better consistency upon employment of a boron 
trichloride (Table 1, entry 14). Since boron trifluoride and boron trichloride catalysts have 
been tested, we decided to also try boron tribromide as a catalyst. It catalyzed the 
formation of product 2a in a modest 20% yield (Table 1, entry 15). 
 
3.2 PROPOSED MECHANISM 
 
Scheme 34 illustrates the proposed mechanistic pathway for the ynone formation 
reaction. Interaction of the alkynyltrifluoroborate species with boron trichloride results in 
the formation of an organodichloroborane species.[73] The electrophilic 
organodichloroborane species coordinates with the acyl chloride resulting in the 
formation of a nucleophilic borate and an activated carbonyl group. A tetrahedral 
intermediate is formed by transfer of the alkynyl group from the borate to the 
electrophilic carbonyl.[74] The desired ynone product is formed upon collapse of the 
tetrahedral intermediate. 
 




3.3 RESULTS AND DISCUSSION: ACYL CHLORIDE SCOPE 
  
Upon successful optimization of the conditions for the preparation of ynone 2a, the next 
step was to explore the scope and functional group tolerance of the acyl chloride starting 
material.  
 
3.3.1 SUCCESSFUL EXPERIMENTS 
 
In order to test the substrate scope, phenylacetylene trifluoroborate 1a was submitted to 
the reaction conditions with a variety of acyl chlorides (Figure 5).  
Unsubstituted naphthyl and biphenyl acyl chlorides afforded the expected ynone 
products in synthetically useful yields (2b,c). Reactions with derivatives of benzoyl 
chloride bearing electron-donating methoxy, methyl, and butyl substituents in the para- 
position as well as the sterically hindered ortho- methylbenzoyl chloride proceeded to 
completion, furnishing the expected products in excellent yields (2d-g). Conversely, 
electron-withdrawing group bearing acyl chlorides proved to be more challenging 
substrates (2h,i,m). Interestingly, the yield of reaction of ortho- chlorobenzoyl chloride 
with 1a was nearly double compared to that of para- chlorobenzoyl chloride (2h, i). It is 
possible that the steric interaction of the ortho- substituent forces the carbonyl functional 
group out of the plane of the aromatic ring, offsetting the electron-withdrawing character 
of the group. We also had success with non-aromatic acyl chlorides (1j-m). Cyclohexyl and 
cylopropyl carbonyl chlorides as well as acetyl chloride reacted to form the expected 
ynones in good yields (2j-l). 4-Bromobutyryl chloride reacted to furnish the corresponding 
ynone in 39% yield (2m). This is particularly noteworthy since, to our knowledge, this is 












   
Figure 5: Products obtained by the reaction of phenylacetylene trifluoroborate 
salt 1a with various acyl chlorides.  
Reactions were run with 1 equiv of acyl chloride, 1.5 equiv potassium phenylacetylenetrifluoroborate 1a, 
and 1.5 equiv boron trichloride.  
 
3.3.2 UNSUCCESSFUL EXPERIMENTS 
 
The substrate scope of this methodology allows for the use of aryl and aliphatic acyl 
chlorides with a variety of functional groups present (Figure 5). However, not all acyl 
chlorides submitted to the reaction conditions resulted in the clean formation of the 




Figure 6: Acyl chlorides that did not result in ynone formation 
 
Benzoyl chloride derivatives bearing strongly electron withdrawing groups such as 4-
nitrobenzoyl chloride and 4-trifluoromethylbenzoyl chloride did not result in the 
formation of ynone products under the optimized conditions. The strongly electron-
withdrawing nature of these groups results in an electron deficient carbonyl group that is 
less likely to act as a Lewis base. The reaction may not proceed since the carbonyl group 
is not prone to donate a pair of electrons to the organodichloroborane species and 
therefore the alkynyl group transfer does not take place (Scheme 34).  
Acyl chlorides bearing Lewis basic heteroatom functional groups such as benzothiophene-
2-carbonyl chloride were also found to be unsuitable for the reaction. In this case, the 
basic electron pairs on the sulfur group may interfere with the reaction by interacting with 
the trivalent dichloroborane species. 
Alkenyl acyl chlorides such as trans-crotonyl chloride and trans-cinnamoyl chloride also 
proved unsuccessful in generating the desired ynones under the developed conditions. 
Side products may be produced as a result of transfer of the alkynyl group to the β-carbon. 
Additionally, trivalent boron is known to interact with alkenes, for example in 
hydroboration reactions.[75] As a result, the presence of a double bond can result in a 




3.4 RESULTS AND DISCUSSION: TRIFLUOROBORATE SCOPE 
 
The scope of the methodology was further explored by submitting several other examples 
of potassium alkynyltrifluoroborate salts to the developed reaction conditions (Figure 7). 
Derivatives of phenylacetylene trifluoroborate bearing electron-donating butyl- and 
methoxy- substituents in the para- position reacted with aromatic and aliphatic acyl 
chlorides to form the anticipated ynones in good to excellent yields (3a-c, 4a-c). In most 
cases, the presence of the electron donating group on the alkynyltrifluoroborate 
significantly improved the yield of the reaction. For example, the yield of ynone obtained 
from 4-bromobutyryl chloride increased from 39% when reacted with neutral 
phenylacetylenetrifluoroborate (2m, Figure 5) to 81% when reacted with electron-rich 
para-butyl phenylacetylenetrifluoroborate (3c). The yield of ynone obtained from neutral 
benzoyl chloride increased from 67% for phenylacetylenetrifluoroborate (2a, Table 1) to 
75% and 87% for electron-rich para-methoxy and para-butyl 
phenylacetylenetrifluoroborates, respectively (3a, 4a). Aliphatic alkynyltrifluoroborate 
salt derivatives were found to be less reactive starting materials. However, modest yields 
were obtained when electron-rich para-methoxybenzoyl chloride was reacted with 
hexynyl- and cyclopentylethynyl trifluoroborate (5a, 6a). 
The appearance of an impurity in the fluorine NMR may account for some of the 
difficulties encountered with the cyclopentylethynyl and hexynyl trifluoroborate salts. A 
peak that appears near 148.35ppm, representative of a boron tetrafluoride impurity,[76] is 
much more pronounced for these particular salts than the other trifluoroborate salts that 











Figure 7: Reactions of various alkynyltrifluoroborates with acyl 
chlorides. 
Reactions were run with 1 equiv of acyl chloride, 2.5 equiv potassium alkynyltrifluoroborate     
salt and 2.5 equiv boron trichloride. 
 
 
4. PREPARATION OF STERICALLY HINDERED YNONES 
 
Once a procedure has been developed for the preparation of ynones from 
alkynyltrifluoroborate salts, we began to work towards the preparation of sterically 




4.1 METHODOLOGY DEVELOPMENT 
 
4.1.1 ATTEMPTS TO PREPARE STERICALLY HINDERED YNONES VIA ACYL 
CHLORIDE INTERMEDIATE 
 
The limited commercial availability of substituted benzoyl chloride derivatives prompted 
us to explore the use of substituted benzoic acid derivatives as starting materials. Initially, 
we attempted to convert the sterically hindered ortho-hydroxy substituted benzoic acid 
11 to an acyl chloride, which could subsequently be submitted to the developed 
conditions for ynone preparation (Scheme 35). Direct conversion of acid 11 to an acyl 
chloride using thionyl chloride was not successful. Allyl bromide was used to protect the 
acid and phenol functional groups. Selective deprotection of the acid group with sodium 
hydroxide followed by exposure to thionyl chloride was expected to produce protected 
benzoyl chloride 13. Once compound 13 is prepared, conversion to the desired ynone is 
expected to be straightforward. Unfortunately, the conditions required to convert 12 to 
13 resulted in some decomposition of the starting material making isolation of clean 
product a challenge. In addition to the challenges encountered, the number of steps 
required for this procedure is inconvenient and, therefore, we decided to seek alternative 
methods. 
 
Scheme 35: Attempted synthesis of benzoyl chloride 3.  
 
Our next strategy was to protect the carboxylic acid starting material using tert-
butyldimethylsilyl chloride. Protected acid 14 can be directly transformed to an acyl 
chloride using oxalyl chloride.[77] The protected acyl chloride was then reacted with para-
methoxy phenylacetylenetrifluoroborate 1c under the developed reaction conditions 
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(Scheme 36). Ynone formation did proceed as expected and, additionally, the 
simultaneous demethylation of the ortho-methoxy group was observed. Mono-
demethylated ynone product 15 was obtained in 16% yield. The poor yield of this reaction 
may be attributed to impurities in the acyl chloride intermediate, steric bulk associated 
with the silyl protecting group, as well as insufficient boron trichloride available to both 
catalyze the transfer of the alkynyl group of the trifluoroborate[73-74] and demethylate the 
ortho-methoxy group.[78]  
 
Scheme 36: Formation of ortho-demethylated ynone from ortho-hydroxy 
substituted benzoic acid. 
 
4.1.2 PREPARATION OF YNONES FROM ANHYDRIDES 
 
The observed ortho-demethylation under the optimized reaction conditions led us to 
begin using 2,4,6-trimethoxy substituted starting materials in place of the more costly 
ortho-hydroxy substituted acid. 2,4,6-trimethoxybenzoic acid was converted to acyl 
chloride 16 using oxalyl chloride. Conversion to 16 was incomplete, however, we 
proceeded with the next step of the synthesis. The anticipated ortho-demethylated ynone 
8a was obtained in 25% yield when 16 was submitted to the boron trichloride catalyzed 
conditions in the presence of para-methoxy phenylacetylenetrifluoroborate 1c (Scheme 
37). Incomplete conversion of the acid starting material to the acyl chloride intermediate 




Scheme 37: Preparation of sterically hindered ynone from mixed anhydride 
and acyl chloride starting materials.  
 
The need for harsh reaction conditions to convert the commercially available carboxylic 
acid starting material to the desired acyl chloride in addition to challenges with 
incomplete conversion prompted us to explore alternative starting materials. Anhydrides 
have similar reactivity to acyl chlorides, and, therefore, we hypothesized that an 
anhydride substrate might form the desired ynone product under the same conditions. As 
a proof of concept we submitted acetic anhydride to the optimized reaction conditions in 
the presence of phenylacetylenetrifluoroborate 1a (Scheme 38). We were pleased to 
obtain the expected ynone 2l in 44% yield, a 10% reduction from the yield obtained for 
the analogous reaction using acetyl chloride. The slightly reduced yield was expected since 
anhydrides are less reactive than acyl chlorides.  
 
Scheme 38: Ynone preparation from acetic anhydride and phenylacetylene 
trifluoroborate. 
 
With the knowledge that anhydrides can react with trifluoroborates to form ynones, we 
set out to prepare mixed anhydride 7a from 2,4,6-trimethoxybenzoic acid and acetyl 
chloride in the presence of triethylamine.[79] Given that electron-donating substituents 
favour product formation under the developed methodology, we predicted that there 
would be insignificant formation of the unwanted acetyl ynone side product upon 
submission of the mixed anhydride to the developed conditions. We were pleased to 
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obtain o-alkynoylphenol 8a in 34% yield on our first attempt to react the trimethoxy 
substituted mixed anhydride starting material with para-methoxy 
phenylacetylenetrifluoroborate 1c (Scheme 37). 
A 45% yield of the expected ortho-demethylated ynone product was obtained when 
trimethoxy substituted mixed anhydride 7a was reacted with 1.5 equivalents of 
phenylacetylenetrifluoroborate 1a in the presence of 1.5 equivalents of boron trichloride 
catalyst (Scheme 39). We hypothesized that boron trichloride now performs the dual 
function of catalyzing the transfer of the alkynyl group[73-74] and selective ortho- 
demethylation of a methoxy group.[78] This led us to increase the number of equivalents 
of boron trichloride in order to ensure that both product formation and demethylation 
takes place. Doubling the quantity of boron trichloride catalyst to 3.0 equivalents resulted 
in a yield increase to 71% for ynone 8b (Scheme 39). 
 
Scheme 39: Preparation of ortho-demethylated ynone from mixed anhydride 
starting material. 
 
4.2 RESULTS AND DISCUSSION: PREPARATION OF 
STERICALLY HINDERED O-ALKYNOYLPHENOLS 
 
Once the conditions for the straightforward preparation of sterically hindered o-
alkynoylphenols have been established, we set out to explore the scope of the reaction 
by preparing several examples from substituted mixed anhydrides and 
alkynyltrifluoroborate salts (Figure 8). Good yields of the desired o-alkynoylphenols were 
obtained when phenylacetylenetrifluoroborate 1a was reacted with 2,4,6-trimethoxy and 
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2,6-dimethoxy substituted mixed anhydrides (8b-c). 1-Ethynylnaphthyl trifluoroborate 
also reacted with 2,6-dimethoxy substituted mixed anhydride under the developed 
conditions to produce o-alkynoylphenol 8e in good yield. When electron-rich para-
methoxy phenylacetylenetrifluoroborate 1c was reacted with the trimethoxy substituted 
mixed anhydride with the optimized equivalents of catalyst the yield increased from 34% 
to 49%. It appears that the presence of multiple electron-donating groups can reduce the 
yield of the reaction. When 1c was reacted with the dimethoxy substituted mixed 
anhydride the desired product was obtained in 76% yield (8d). Conversely, electron 
deficient meta-fluorophenylacetylene trifluoroborate 1g furnished a relatively modest 









Figure 8: Preparation of sterically hindered ortho-demethylated ynones from 
mixed anhydride starting materials.  
Reactions were performed with anhydride 7 (0.1 mmol), alkynyltrifluoroborate 1 (0.15 mmol), and boron 
trichloride (3.0 equiv.) at room temperature for 45 min under air. Yield of isolated product after purification 
by silica gel chromatography.  
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5. CYCLIZATION OF O-ALKYNOYLPHENOLS 
 
Once a library of o-alkynoylphenols was prepared, we set out to cyclize the products under 
basic and acidic conditions in order to form aurone and flavone scaffolds, respectively. 
 
5.1 BASE PROMOTED 5-EXO CYCLIZATION OF O-
ALKYNOYLPHENOLS  
 
Under basic conditions the 5-exo and 6-endo cyclization pathways are competing, with 
formation of the major product depending on the conditions employed.[34a, 34b, 34d] Initially, 
when we set out to produce flavones, we attempted to employ cesium carbonate to 
promote the 6-endo cyclization of the o-alkynoylphenols.[36, 80] We observed that rapid 5-
exo cyclization takes place under these conditions. Aurones 10a-e were formed in good 
to excellent yields by stirring the o-alkynoylphenol precursors with cesium carbonate in 
acetone at room temperature (Figure 9). 
 
5.2 ACID PROMOTED 6-ENDO CYCLIZATION OF O-
ALKYNOYLPHENOLS 
 
Regioselective 6-endo cyclization of o-alkynoylphenols may be achieved by applying the 
principles of the Morita-Baylis-Hillman reaction.[69] Intramolecular Michael addition may 
be promoted via 1,4-addition of a nucleophile to the β-carbon in the ynone system. 





Scheme 40: Catalytic cycle for the 6-endo cyclization of o-alkynoylphenols 
 
5.3 RESULTS AND DISCUSSION: AURONE AND FLAVONE 
SYNTHESIS  
 
We have employed trifluoromethanesulfonic acid (TfOH) as a catalyst in order to promote 
the 6-endo cyclization of the synthesized o-alkynoylphenols.[34f] This method was 
successful in promoting the regioselective 6-endo cyclization of o-alkynoylphenols to 
produce flavones in moderate to excellent yields (Figure 9, 9a-e). The presence of an 
additional electron-rich methoxy- functional group on the phenol ring improved the yield 
from 76% for 9a to 97% for 9b. Conversely, the addition of a methoxy group to aromatic 
ring adjacent to the triple bond reduced the yields to 51% and 55% for flavones 9c and 9d, 
respectively. Similarly, a modest yield of 32% was obtained for the cyclization of the o-
alkynoylphenol in the presence of a bulky, electron-rich naphthyl group. 
Once 1,4-addition of the TfOH to the o-alkynoylphenol has taken place, the phenol oxygen 
acts as a nucleophile in the intramolecular 6-endo cyclization (Scheme 40). The 
observation that the cyclization is more efficient when electron-rich functional groups are 
present on the phenol ring is due to the increased nucleophilicity of oxygen. On the other 
hand, the presence of electron-rich groups on the aryl group originating from the 
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alkynyltrifluoroborate tend to increase electron density around the electrophilic carbon 








Figure 9: Acid and base promoted ynone cyclization products.  
9a-e were prepared with TfOH (5 equiv.) at 80oC. [a] Reaction was performed at 40oC. 10a-e were 
prepared with Cs2CO3 (3 equiv.) at room temperature. 
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The cesium carbonate promoted 5-exo cyclization of o-alkynoylphenols to form aurones 
was straightforward and resulted in good to excellent yields (Figure 9, 10a-e). Cyclization 
of both o-alkynoylphenols derived from neutral phenylacetylenetrifluoroborate 1a 
yielded the corresponding aurones in very good yields (10a,b). O-Alkynoylphenols bearing 
electron-donating methoxy groups on the aromatic ring alpha- to the triple bond afforded 
the corresponding aurones in near quantitative yields (10c,d). A slight reduction in yield 
to 78% was observed when an electron-withdrawing fluorine atom was present (10e).  
A key piece of evidence supporting the cesium carbonate catalyzed formation of aurones 
rather than flavones can be found by analyzing the 13C NMR spectra. Flavones exhibit a 
peak between 176.3 and 178.3 ppm that is representative of the carbonyl carbon. On the 
other hand the carbonyl carbon on aurone scaffolds appears above 180 ppm.[81] 
Specifically, the cesium carbonate-catalyzed cyclization of o-alkynoylphenols results in the 
formation of the geometric Z-isomer. This is made evident by the location of the =CH 13C 
peak, which differs by about 10 ppm between the two isomers. The =CH 13C peak appears 
near 111 ppm for the Z-isomer and near 121 ppm for the E-isomer.[82] All aurones 
prepared by this method have a 13C NMR peak appearing between 110 and 112 ppm and 
do not have any carbons appearing near 121 ppm. Accordingly, it may be concluded that 
the Z-isomer is being formed. The reduced steric interactions between the carbonyl and 
the aromatic group make the Z-isomer more thermodynamically stable. 
 
6. CONCLUSIONS AND FUTURE DIRECTIONS 
 
A novel methodology for the synthesis of functionalized and sterically hindered ynones 
from potassium alkynyltrifluoroborate salts and acyl chlorides has been developed. 
Operational simplicity is a key feature of this method. The one-pot reaction proceeds 
rapidly in the presence of a boron trichloride catalyst and does not require exclusion of 
air or water. This approach boasts unique functional group tolerance, illustrated by the 
successful preparation of an ynone bearing an alkyl bromide functional group.  
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In order to broaden the applicability of this method for the preparation of ynones, it has 
been expanded to include symmetrical and mixed anhydride starting materials as a 
substitute for acyl chlorides. Compared to acyl chlorides, a wider variety of functionalized 
carboxylic acids are commercially available. This opens up many synthetic opportunities 
given that under basic conditions a desired mixed anhydride may be prepared from a 
carboxylic acid and an acyl chloride such as acetyl chloride. 
In the presence of the boron trichloride catalyst, a selective ortho-demethylation of 2,4,6-
trimethoxy and 2,6-dimethoxy substituted mixed anhydrides is observed. As a result, this 
method lends itself particularly well to the synthesis of o-alkynoylphenol compounds. A 
library of functionalized o-alkynoylphenols has been prepared using the developed 
methodology and further employed toward the production of various natural product 
scaffolds.  
From the o-alkynoylphenol products, a series of aurone and flavone derivatives has been 
prepared. Regioselective 6-endo cyclization of o-alkynoylphenols was facilitated by 
trifluoromethanesulfonic acid catalyst. Contrary to reports from the literature, cesium 
carbonate has been demonstrated to promote the exclusive 5-exo cyclization of o-
alkynoylphenols to for aurone products.  
Future directions of this project involve the preparation of more elaborate flavone natural 
products, for example, through functionalization at carbon 3. Hydroxylation at carbon 3 
of flavones to afford flavonols may be achieved using dimethyldioxirane.[83] Conversion of 
the hydroxyl group to a triflate, for example, would allow for further functionalization at 
this location. Alternatively, iodine-mediated cyclization of o-alkynoylphenols could be 
explored for the synthesis 3-iodoflavones.[84] Preparation of halogenated flavones opens 
up the possibility for further transformations to furnish interesting functionalized 








APPENDIX I: COMPOUND CHARACTERIZATION DATA  
 
 
Potassium trifluoro(phenylethynyl)borate (1a): Derived from phenylacetylene (2.45 g, 
24.0 mmol, 1.0 equiv.), n-BuLi (1.54 g, 24.0 mmol, 1.0 equiv.), B(OMe)3 (3.74 g, 36.0 mmol, 
1.5 equiv.), and aqueous KHF2 (11.25 g, 144 mmol, 6.0 equiv.) in 50 mL THF. Solubilisation 
in acetone and precipitation with diethyl ether afforded product 1a (1.982 g, 40% yield) 
as a white crystalline solid. 1H NMR (DMSO) δ 7.27 (m, 4H), 7.24 (m, 1H); 13C {1H} NMR 
(DMSO) δ 131.0, 128.3, 126.7, 125.5; 19F NMR (DMSO) δ -131.9 (s, 3F); 11B NMR (DMSO) 
δ -1.55 (s, 1B); HRMS (ESI/M-) calcd. for C8H5BF3 169.0442, found 169.0438. 
 
 
Potassium ((4-butylphenyl)ethynyl)trifluoroborate (1b): Derived from 1-butyl-4-
ethynylbenzene (3.00 g, 18.0 mmol, 1.0 equiv.), n-BuLi (1.15 g, 18.0 mmol, 1.0 equiv.), 
B(OMe)3 (2.81 g, 27.0 mmol, 1.5 equiv.), and aqueous KHF2 (8.463 g, 108 mmol, 6.0 equiv.) 
in 50 mL THF. Solubilisation in acetone and precipitation with diethyl ether afforded 
product 1b (2.609 g, 55% yield) as a white crystalline solid. 1H NMR (DMSO) δ 7.19 (dt, J = 
8.20, 1.5 Hz, 2H), 7.09 (d, J = 8.0 Hz, 2H), 2.54 (t, J = 7.5 Hz 2H), 1.52 (m, 2H), 1.28 (dq, J = 
14.80, 7.5 Hz, 2H), 0.88 (t, J = 7.23 Hz, 3H); 13C {1H} NMR (DMSO) δ 140.9, 130.8, 128.2, 
122.8, 34.6, 32.9, 21.7, 13.8; 19F NMR (DMSO) δ -131.6 (s, 3F); 11B NMR (DMSO) δ -1.67 (s, 




Potassium trifluoro((4-methoxyphenyl)ethynyl)borate (1c): Derived from 4-
ethynylanisole (1.00 g, 7.34 mmol, 1.0 equiv.), n-BuLi (0.470 g, 7.34 mmol, 1.0 equiv.), 
B(OMe)3 (1.14 g, 11.0 mmol, 1.5 equiv.), and aqueous KHF2 (3.462 g, 44.3 mmol, 6.0 
equiv.) in 25 mL THF. Solubilisation in acetone and precipitation with diethyl ether 
afforded product 1c (2.609 g, 55% yield) as a white crystalline solid. 1H NMR (DMSO) δ 
7.22 (dt, J = 8.99, 2.5 Hz, 2H), 6.84 (dt, J = 9.0, 2.0 Hz, 2H), 3.73 (s, 3H); 13C {1H} NMR 
(DMSO) δ 158.0, 132.2, 117.7, 113.9, 55.0; 19F NMR (DMSO) δ -131.5 (s, 3F); 11B NMR 
(DMSO) δ -1.67 (s, 1B); HRMS (ESI/M-) calcd. for C9H7OBF3 199.0548, found 199.0543. 
 
 
Potassium (cyclopentylethynyl)trifluoroborate (1d): Derived from cyclopentylacetylene 
(1.10 g, 11.6 mmol, 1.0 equiv.), n-BuLi (0.743 g, 11.6 mmol, 1.0 equiv.), B(OMe)3 (1.79 g, 
17.3 mmol, 1.5 equiv.), and aqueous KHF2 (5.416 g, 69.3 mmol, 6.0 equiv.) in 25 mL THF. 
Solubilisation in acetone and precipitation with diethyl ether afforded product 1d (0.5028 
g, 22% yield) as a white crystalline solid. 1H NMR (DMSO) δ 2.40 (t, J = 8.0 Hz, 1H), 1.76 (m, 
2H), 1.60 (m, 2H), 1.34-1.49 (m, 4H); 13C {1H} NMR (DMSO) δ 33.8, 30.4, 24.4; 19F NMR 
(DMSO) δ -131.5 (s, 3F); 11B NMR (DMSO) δ -1.30 (s, 1B); HRMS (ESI/M-) calcd. for C7H9BF3 








Potassium trifluoro(hex-1-yn-1-yl)borate (1e): Derived from 1-hexyne (2.0 g, 23.6 mmol, 
1.0 equiv.), n-BuLi (1.51 g, 23.6 mmol, 1.0 equiv.), B(OMe)3 (3.68 g, 35.4 mmol, 1.5 equiv.), 
and aqueous KHF2 (11.06 g, 142 mmol, 6.0 equiv.) in 25 mL THF. Solubilisation in acetone 
and precipitation with diethyl ether afforded product 1e (1.659 g, 36% yield) as a white 
crystalline solid. 1H NMR (DMSO) δ 1.98 (m, 2H) 1.33 (m, 4H), 0.85 (m, 3H); 13C {1H} NMR 
(DMSO) δ 31.1, 21.4, 18.5, 13.5; 19F NMR (DMSO) δ -131.0 (s, 3F); 11B NMR (DMSO) δ -1.30 
(s, 1B); HRMS      (ESI/M-) calcd. for C6H9BF3 149.0755, found 149.0749. 
 
 
Potassium (1-naphthyl)ethynyltrifluoroborate  (1f): Derived from 1-ethynylnaphthalene. 
1f was obtained in 62% yield as a pale pink crystalline solid. 1H NMR (DMSO) δ 8.33 (d, J = 
8.2 Hz, 1H), 7.91 (d, J = 7.8 Hz, 1H), 7.82 (d, J = 8.2 Hz, 1H), 7.57 (m, 3H), 7.44 (m, 1H); 13C 
{1H} NMR (DMSO) δ 132.9, 132.8, 128.9, 128.1, 126.9, 126.3, 126.2, 126.1, 125.5, 123.1; 
19F NMR (DMSO) δ -131.5 (s, 3F); 11B NMR (DMSO) δ -1.56(s, 1B); HRMS (ESI/M-) calcd. for 








Potassium (3-fluorophenyl)ethynyltrifluoroborate (1g): Derived from 3-
fluorophenylacetylene. 1g was obtained in 84% yield as a while crystalline solid. 1H NMR 
(DMSO) δ 7.32 (m, 1H), 7.10 (m, 3H); 13C {1H} NMR (DMSO) δ 163.0, 160.6, 130.3 (d, J = 
9.0 Hz, 1C), 127.3, 117.3 (d, J = 22 Hz, 1C), 114.0 (d, J = 21 Hz, 1C); 19F NMR (DMSO) δ -
132.0 (s, 3F), -113.5 (m, 1F); 11B NMR (DMSO) δ -1.82 (s, 1B); HRMS (ESI/M-) calcd. for 
C8H4BF3 187.0348, found 187.0348. 
 
 
1,3-diphenylprop-2-yn-1-one (2a): Derived from benzoyl chloride (16.9 mg, 0.12 mmol, 
1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (37.4 mg, 0.18 mmol, 1.5 
equiv.) and boron trichloride (21.1  mg, 0.18 mmol, 1.5 equiv.) in 0.6 mL of DCM.  
Purification by silica gel column chromatography using hexanes/EtOAc (30/1) and 
pentane wash afforded the product 2a (16.5 mg, 67% yield) as a yellow oil. IR (film) ν 2200, 
1633, 1316, 1290, 762, 688 cm-1; 1H NMR (CDCl3) δ8.23 (m, 2H), 7.70 (m, 2H), 7.64 (tt, J = 
7.5, 2.0 Hz, 1H), 7.47-7.55 (m, 3H), 7.43 (tt, J = 7.5, 1.5 Hz, 2H); 13C {1H} NMR (CDCl3) δ  
178.0, 136.9, 134.1, 133.1, 130.8, 129.6, 128.7, 128.6, 120.1, 93.1, 86.9; HRMS 







1-(naphthalen-2-yl)-3-phenylprop-2-yn-1-one (2b): Derived from 2-naphthoyl chloride 
(19.1 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (31.2 mg, 
0.15 mmol, 1.5 equiv.) and boron trichloride (17.6 mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL of 
DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (30/1) and 
pentane wash afforded the product 2b (16.8 mg, 66% yield) as a pale yellow solid. IR (film) 
ν 2206, 1625, 1305, 1125, 759, 688 cm-1; 1H NMR (CDCl3) δ8.79 (s, 1H), 8.21 (dd, J = 8.5, 
1.5 Hz, 1H), 8.03 (d, J = 8.0 Hz, 1H), 7.92 (t, J = 9.0 Hz, 2H), 7.74 (m, 2H), 7.60 (tdd, J = 15, 
7.0, 1.5 Hz, 2H), 7.51 (tt, J = 7.0, 2.5 Hz, 1H), 7.45 (tt, J = 7.0, 1.5 Hz, 2H); 13C {1H} NMR 
(CDCl3) δ 177.9, 136.2, 134.4, 133.1, 132.6, 132.4, 130.8, 129.9, 129.0, 128.7, 128.5, 127.9, 




1-([1,1'-biphenyl]-4-yl)-3-phenylprop-2-yn-1-one (2c): Derived from biphenyl-4-carbonyl 
chloride (43.3 mg, 0.20 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) 
(62.4 mg, 0.30 mmol, 1.5 equiv.) and boron trichloride (35.2  mg, 0.30 mmol, 1.5 equiv.) 
in 1.0 mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc 
(25/1) and pentane wash afforded the product 2c (30.1 mg, 53%) as a yellow solid. IR (film) 
ν 2202, 1634, 1288, 1214, 1174, 1012, 741, 689 cm-1; 1H NMR (CDCl3) δ8.29 (m, 2H), 7.71 
(m, 4H), 7.65 (m, 2H), 7.48 (m, 3H) 7.42 (t, J = 7.0 Hz, 3H); 13C {1H} NMR (CDCl3) δ  177.5, 
146.8, 139.7, 135.7, 133.0, 130.7, 130.1, 129.0, 128.7, 128.4, 127.3, 127.2, 120.1, 93.1, 




1-(4-methoxyphenyl)-3-phenylprop-2-yn-1-one (2d): Derived from 4-methoxybenzoyl 
chloride (17.1 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) 
(31.2 mg, 0.15 mmol, 1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) 
in 0.5 mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc 
(10/1) afforded the product 2d (27.7 mg, quantitative yield) as a beige solid. IR (film) ν 
2199, 1628, 1601, 1259, 1159, 762, 683 cm-1; 1H NMR (CDCl3) δ8.20 (dt, J = 9.0, 2.5 Hz, 
2H), 7.67 (dt, J = 7.0, 1.5 Hz, 2H), 7.44 (dtt, J = 24, 7.0, 1.5 Hz, 3H), 6.98 (dt, J = 9.0, 2.5 Hz, 
2H), 3.89 (s, 3H); 13C {1H} NMR (CDCl3) δ 176.6, 164.5, 132.9, 131.9, 130.6, 128.6, 120.3, 
113.9, 92.3, 86.9, 55.6; HRMS (ESI/[M+H]+) calcd. for C16H12O2 237.0910, found 237.0910. 
 
 
1-(4-butylphenyl)-3-phenylprop-2-yn-1-one (2e): Derived from 4-butylbenzoyl chloride 
(23.6 mg, 0.12 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (37.4 mg, 
0.18 mmol, 1.5 equiv.) and boron trichloride (21.1  mg, 0.18 mmol, 1.5 equiv.) in 0.6 mL 
of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (30/1) 
afforded the product 2e (33.5 mg, quantitative yield) as a copper coloured oil. IR (film) ν 
2199, 1638, 1605, 1312, 1011, 756, 689 cm-1; 1H NMR (CDCl3) δ8.14 (d, J = 8.0 Hz, 2H), 
7.68 (d, J = 7.5 Hz, 2H), 7.45 (m, 3H), 7.32 (d, J = 8.0 Hz, 2H), 2.70 (t, J = 8.0 Hz, 2H), 1.64 
(m, 2H), 1.38 (dq, J = 15, 7.5 Hz, 2H), 0.94 (t, J = 7.5 Hz, 3H); 13C {1H} NMR (CDCl3) δ  178.0, 
136.9, 134.1, 133.1, 130.8, 129.6, 128.7, 128.6, 120.1, 93.1, 86.9; HRMS (APCI/[M+H]+) 




3-phenyl-1-(p-tolyl)prop-2-yn-1-one (2f): Derived from p-toluoyl chloride (15.5 mg, 0.10 
mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (31.2 mg, 0.15 mmol, 
1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL of DCM.  
Purification by silica gel column chromatography using hexanes/EtOAc (25/1) afforded the 
product 2f (24.6 mg, quantitative yield) as a light brown solid. IR (film) ν 2202, 1634, 1603, 
1286,  1169, 761, 690 cm-1; 1H NMR (CDCl3) δ8.12 (d, J = 8.5 Hz, 2H), 7.68 (dt, J = 7.0, 1.5 
Hz, 2H), 7.45 (dtt, J = 25, 7.0, 1.0 Hz, 3H), 7.31 (d, J = 8.0 Hz, 2H), 2.24 (s, 3H); 13C {1H} NMR 
(CDCl3) δ  145.2, 134.6, 133.0, 130.7, 129.7, 129.3, 128.6, 120.3, 92.6, 87.0, 21.8; HRMS 
(APCI/[M+H]+) calcd. for C16H12O 221.0961, found 221.0960.  
 
 
3-phenyl-1-(o-tolyl)prop-2-yn-1-one (2g): Derived from o-toluoyl chloride (15.5 mg, 0.10 
mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (31.2 mg, 0.15 mmol, 
1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL of DCM.  
Purification by silica gel column chromatography using hexanes/EtOAc (20/1) and 
pentane wash afforded the product 2g (21.4 mg, 97%) as a yellow oil. IR (film) ν 2361, 
2197, 1638, 1307, 1202, 1008, 730, 688 cm-1; 1H NMR (CDCl3) δ8.30 (dd, J = 7.5, 1.0 Hz, 
1H), 7.65 (dt, J = 7.0, 2.0 Hz, 2H), 7.34-7.48 (m, 5H), 7.26 (m, 1H), 2.68 (s, 3H); 13C {1H} NMR 
(CDCl3) δ  179.7, 140.4, 135.7, 133.1, 132.9, 132.8, 132.1, 130.5, 128.6, 125.8, 120.3, 91.8, 




1-(4-chlorophenyl)-3-phenylprop-2-yn-1-one (2h): Derived from p-chlorobenzoyl 
chloride (17.5 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) 
(32.0 mg, 0.15 mmol, 1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) 
in 0.5 mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc 
(20/1) and pentane wash afforded the product 2h (7.2 mg, 30%) as a pale yellow solid. IR 
(film) ν 2199, 1651, 1584, 1287, 1008, 751 cm-1; 1H NMR (CDCl3) δ8.15 (dt, J = 8.5, 2.5 Hz, 
2H), 7.68 (dt, J = 7.0, 1.5 Hz, 2H), 7.50 (m, 3H), 7.43 (m, 2H); 13C {1H} NMR (CDCl3) δ  176.7, 
140.7, 135.3, 133.1, 131.0, 130.9, 129.0, 128.7, 119.9, 93.6, 86.6; HRMS (EI/M+) calcd. for 
C15H9ClO 240.0342, found 240.0339. 
 
 
1-(2-chlorophenyl)-3-phenylprop-2-yn-1-one (2i): Derived from o-chlorobenzoyl chloride 
(17.5 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (31.2 mg, 
0.15 mmol, 1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL 
of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (20/1) 
and pentane wash afforded the product 2i (14.1 mg, 59%) as a yellow oil. IR (film) ν 2359, 
2196, 1650, 1303, 1009, 740, 687 cm-1; 1H NMR (CDCl3) δ8.09 (m, 1H), 7.65 (dt, J = 6.5, 2.0 
Hz, 2H), 7.48 (m, 3H), 7.41 (m, 3H); 13C {1H} NMR (CDCl3) δ  176.8, 135.9, 133.6, 133.3, 
133.1, 132.5, 131.5, 130.9, 128.7, 126.8, 120.0, 93.9, 88.3; HRMS (EI/M+) calcd. for 




1-cyclohexyl-3-phenylprop-2-yn-1-one (2j): Derived from cyclohexanecarbonyl chloride 
(14.7 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (31.2 mg, 
0.15 mmol, 1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL 
of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (25/1) 
and pentane wash afforded the product 2j (16.8 mg, 78% yield) as a pale yellow oil. IR 
(film) ν 2932, 2360, 2199, 1664, 758, 689 cm-1; 1H NMR (CDCl3) δ7.57 (m, 2H), 7.45 (tt, J = 
7.5, 2.5 Hz, 1H), 7.38 (m, 2H), 2.51 (tt, J = 11, 3.5 Hz, 1H), 2.06 (m, 2H), 1.82 (m, 2H), 1.68 
(m, 1H), 1.50 (qd, J = 11.98, 3.13 Hz, 2H); 1.22-1.40 (m, 3H); 13C {1H} NMR (CDCl3) δ 191.5, 
133.0, 130.5, 128.6, 120.1, 91.3, 87.2, 52.3, 28.3, 25.8, 25.4; HRMS (ESI/[M+H]+) calcd. for 
C15H16O 213.1274, found 213.1269. 
 
 
1-cyclopropyl-3-phenylprop-2-yn-1-one (2k): Derived from cyclopropanecarbonyl 
chloride (20.9 mg, 0.20 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) 
(62.4 mg, 0.30 mmol, 1.5 equiv.) and boron trichloride (35.2 mg, 0.30 mmol, 1.5 equiv.) in 
1.0 mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc 
(30/1) and pentane wash afforded the product 2k (26.8 mg, 79%) as a yellow oil. IR (film) 
ν 2362, 2205, 1654, 1108, 798, 688 cm-1; 1H NMR (CDCl3) δ7.56 (dd, J = 8.0, 1.5 Hz, 2H), 
7.45 (t, J = 7.5 Hz, 1H), 7.38 (t, J = 7.0 Hz, 2H), 2.16 (tt, J = 8.0, 4.5 Hz, 1H), 1.33 (m, 2H), 
1.09 (m, 2H); 13C {1H} NMR (CDCl3) δ 188.3, 132.9, 130.5, 128.6, 120.0, 90.4, 86.1, 24.5, 




4-phenylbut-3-yn-2-one 2l): Derived from acetyl chloride (15.7 mg, 0.20 mmol, 1.0 
equiv.), potassium trifluoro(phenylethynyl)borate (1a) (62.4 mg, 0.30 mmol, 1.5 equiv.) 
and boron trichloride (35.2  mg, 0.30 mmol, 1.5 equiv.) in 1.0 mL of DCM.  Purification by 
silica gel column chromatography using hexanes/EtOAc (30/1) and pentane wash afforded 
the product 2l (15.6 mg, 54%) as a brown oil. IR (film) ν 2202, 1672, 1280, 1157, 977, 758, 
689 cm-1; 1H NMR (CDCl3) δ7.57 (dt, J = 7.0, 1.5 Hz, 2H), 7.45 (dt, J = 8.0, 1.5 Hz, 1H), 7.37 
(tt, J = 7.0, 2.0, 2H), 2.45 (s, 3H); 13C {1H} NMR (CDCl3) δ 184.6, 133.0, 130.7, 128.6, 119.9, 
90.3, 88.2, 32.7; HRMS (EI/M+) calcd. for C10H8O 144.0575, found 144.0571. 
 
 
6-bromo-1-phenylhex-1-yn-3-one (2m): Derived from 4-bromobutyryl lhloride (18.5 mg, 
0.10 mmol, 1.0 equiv.), potassium trifluoro(phenylethynyl)borate (1a) (32.0 mg, 0.15 
mmol, 1.5 equiv.) and boron trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL of 
DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (15/1) 
afforded the product 2m (9.8 mg, 39%) as a yellow oil. IR (film) ν 2201, 1669, 1489, 1283, 
1086, 758, 689 cm-1; 1H NMR (CDCl3) δ7.58 (m, 2H), 7.46 (m, 1H), 7.39 (m, 2H), 3.49 (td, J 
= 6.5, 1.0 Hz, 2H) 2.89 (td, J = 7.0, 1.0 Hz, 2H) 2.27 (quin, J = 6.0, 2H); 13C {1H} NMR (CDCl3) 
δ  186.2, 133.1, 130.8, 128.6, 119.7, 91.2, 87.6, 43.5, 32.6, 26.7; HRMS (ESI/[M+H]+) calcd. 




3-(4-butylphenyl)-1-phenylprop-2-yn-1-one (3a): Derived from benzoyl chloride (14.1 
mg, 0.10 mmol, 1.0 equiv.), potassium ((4-butylphenyl)ethynyl)trifluoroborate (1b) (66.0 
mg, 0.25 mmol, 2.5 equiv.) and boron trichloride (29.3  mg, 0.25 mmol, 2.5 equiv.) in 0.5 
mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (20/1) 
and pentane wash afforded the product 3a (22.9 mg, 87%) as a copper coloured oil. IR 
(film) ν 2196, 1639, 1290, 1212, 1171, 1010, 699cm-1; 1H NMR (CDCl3) δ8.23 (dt, J = 8.0, 
1.5 Hz, 2H), 7.62 (m, 3H), 7.51 (t, J = 8.0 Hz, 2H), 7.25 (m, 2H), 2.66 (t, J = 8.0 Hz, 2H), 1.62 
(m, 2H), 1.37 (dq, J = 15, 7.5 Hz, 2H), 0.94 (t, J = 7.0 Hz, 3H); 13C {1H} NMR (CDCl3) δ 178.0, 
146.5, 137.0, 134.0, 133.1, 129.5, 128.8, 128.6, 117.1, 93.9, 86.8, 35.8, 33.2, 22.3, 13.9; 
HRMS (APCI/[M+H]+) calcd. for C19H18O 263.1430, found 263.1428.  
 
 
3-(4-butylphenyl)-1-(2-chlorophenyl)prop-2-yn-1-oneone (3b): Derived from 2-
chlorobenzoyl chloride (17.5 mg, 0.10 mmol, 1.0 equiv.), potassium ((4-
butylphenyl)ethynyl)trifluoroborate (1b) (66.0 mg, 0.25 mmol, 2.5 equiv.) and boron 
trichloride (29.3  mg, 0.25 mmol, 2.5 equiv.) in 0.5 mL of DCM.  Purification by silica gel 
column chromatography using hexanes/EtOAc (20/1) and pentane wash afforded the 
product 3b (25.2 mg, 85%) as a copper coloured oil. IR (film) ν 2360 , 2193, 1646, 1302, 
1005, 741 cm-1; 1H NMR (CDCl3) δ8.07 (d, J = 8.5 Hz, 1H), 7.56 (d, J = 8.0 Hz, 2H), 7.48 (m, 
2H), 7.40 (m, 1H), 7.22 (d, J = 8.0 Hz, 2H), 2.65 (t, J = 8.0 Hz, 2H), 1.61 (dt, J = 15, 7.5 Hz, 
2H), 1.35 (dq, J = 15, 7.0 Hz, 2H), 0.93 (t, J = 7.5 Hz, 3H); 13C {1H} NMR (CDCl3) δ 176.8, 
146.7, 136.0, 133.4, 133.2, 133.1, 132.4, 131.5, 128.8, 126.7, 117.1, 94.8, 88.3, 35.8, 33.2, 




6-bromo-1-(4-butylphenyl)hex-1-yn-3-one (3c): Derived from 4-bromobutyryl chloride 
(18.5 mg, 0.10 mmol, 1.0 equiv.), potassium ((4-butylphenyl)ethynyl)trifluoroborate (1b) 
(66.0 mg, 0.25 mmol, 2.5 equiv.) and boron trichloride (29.3  mg, 0.25 mmol, 2.5 equiv.) 
in 0.5 mL of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc 
(20/1) and pentane wash afforded the product 3c (24.8 mg, 81%) as a tawny brown oil. IR 
(film) ν 2930, 2360, 2197, 1669, 1085, 833 cm-1; 1H NMR (CDCl3) δ7.49 (d, J = 8.0 Hz, 2H), 
7.20 (d, J = 8.0 Hz, 2H), 3.49 (t, J = 6.5 Hz, 2H), 2.88 (t, J = 7.0 Hz, 2H), 2.64 (t, J = 7.0 Hz, 
2H), 2.5 (quin, J = 6.5 Hz, 2H), 1.60 (m, 2H), 1.35 (dq, J = 15., 7.5 Hz, 2H), 0.92 (t, J = 7.5 Hz, 
3H); 13C {1H} NMR (CDCl3) δ 186.2, 146.6, 133.2, 128.8, 116.8, 92.0, 87.5, 43.5, 35.7, 33.2, 
32.6, 26.8, 22.3, 13.9; HRMS (ESI/[M+H]+) calcd. for C16H19BrO 307.0692, found 307.0685. 
 
 
3-(4-methoxyphenyl)-1-phenylprop-2-yn-1-one (4a): Derived from benzoyl chloride 
(14.1 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro((4-methoxyphenyl)ethynyl)borate 
(1c) (59.5 mg, 0.25 mmol, 2.5 equiv.) and boron trichloride (29.3  mg, 0.25 mmol, 2.5 
equiv.) in 0.5 mL of DCM.  Purification by silica gel column chromatography using 
hexanes/EtOAc (20/1) and pentane wash afforded the product 4a (17.8 mg, 75%) as a 
yellow solid. IR (film) ν 2188, 1625, 1599, 1512, 1255, 1211, 1171, 1032, 836, 698 cm-1; 
1H NMR (CDCl3) δ8.22 (d, J = 8.0 Hz, 2H), 7.63 (m, 3H), 7.51 (t, J = 7.0 Hz, 2H), 6.93 (d, J = 
8.0 Hz, 2H), 3.86 (s, 3H); 13C {1H} NMR (CDCl3) δ 178.0, 161.7, 137.0, 135.1, 133.9, 129.5, 





3-(4-methoxyphenyl)-1-(naphthalen-2-yl)prop-2-yn-1-one (4b): Derived from 2-
naphthoyl chloride (19.1 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro((4-
methoxyphenyl)ethynyl)borate (1c) (34.5 mg, 0.15 mmol, 1.5 equiv.) and boron 
trichloride (17.6  mg, 0.15 mmol, 1.5 equiv.) in 0.5 mL of DCM.  Purification by silica gel 
column chromatography using hexanes/EtOAc (10/1) and pentane wash afforded the 
product 4b (19.9 mg, 70% yield) as a tan solid. IR (film) ν 2192, 1601, 1508, 1257, 159, 
1128, 1042, 829, 751 cm-1; 1H NMR (CDCl3) δ8.77 (s, 1H), 8.21 (dd, J = 8.5, 1.5 Hz, 1H), 8.03 
(d, J = 8.0 Hz, 1H), 7.91 (t, J = 8.0 Hz, 2H), 7.69 (dt, J = 9.0, 7.62 (td, J = 8.0, 1.0,  Hz, 1H), 
7.57 (td, J = 8.0, 1.0 Hz, 1H), 6.95 (dt, J = 8.5, 2.5 Hz, 1H), 3.86 (s, 3H); 13C {1H} NMR (CDCl3) 
δ 177.9, 161.7, 136.1, 135.1, 134.6, 132.4, 132.3, 129.8, 128.9, 128.4, 127.9, 126.9, 124.1, 












1-cyclohexyl-3-(4-methoxyphenyl)prop-2-yn-1-one (4c): Derived from 
cyclohexancarbonyl chloride (14.7 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro((4-
methoxyphenyl)ethynyl)borate (1c) (59.5 mg, 0.25 mmol, 2.5 equiv.) and boron 
trichloride (29.3  mg, 0.25 mmol, 2.5 equiv.) in 0.5 mL of DCM.  Purification by silica gel 
column chromatography using hexanes/EtOAc (15/1) and pentane wash afforded the 
product 4c (16.9 mg, 70% yield) as a beige solid. IR (film) ν 2929, 2188, 1650, 1602, 1255, 
837 cm-1; 1H NMR (CDCl3) δ 7.53 (dt, J = 9.0, 2.5 Hz, 2H), 6.89 (dt, J = 9.0, 3.0 Hz, 2H), 3.84 
(s, 3H), 2.48 (tt, J = 12, 2.5 Hz, 1H), 2.04 (m, 2H), 1.81 (dt, J = 13, 3.5  Hz, 2H), 1.67 (m, 1H), 
1.49 (m, 2H), 1.29 (m, 3H); 13C {1H} NMR (CDCl3) δ 191.5, 161.5, 135.0, 114.3, 112.0, 92.4, 
87.1, 55.4, 52.2, 28.4, 25.8, 25.4; HRMS (ESI/[M+H]+) calcd. for C16H18O2 243.1380, found 
243.1379. 
 
3-cyclopentyl-1-(4-methoxyphenyl)prop-2-yn-1-one (5a): Derived from 4-
methoxybenzoyl chloride (34.1 mg, 0.20 mmol, 1.0 equiv.), potassium 
(cyclopentylethynyl)trifluoroborate (1d) (60.0 mg, 0.30 mmol, 1.5 equiv.) and boron 
trichloride (35.2  mg, 0.30 mmol, 1.5 equiv.) in 1.0 mL of DCM.  Purification by silica gel 
column chromatography using hexanes/EtOAc (10/1) afforded the product 5a (18.2 mg, 
40%) as a pale yellow oil. IR (film) ν 2206, 1629, 1596, 1254, 1169, 1024, 859, 759 cm-1; 1H 
NMR (CDCl3) δ 8.10 (dt, J = 9.0, 2.5 Hz, 2H), 6.94(dt, J = 9.0, 2.5 Hz, 2H), 3.88 (s, 3H), 2.90 
(dt, J = 14, 7.5 Hz,   1H), 2.05 (m, 2H), 1.81 (m, 4H), 1.64 (m, 2H); 13C {1H} NMR (CDCl3) δ 
177.0, 164.1, 131.8, 130.4, 113.7, 100.0, 79.1, 55.5, 33.3, 30.3, 25.2; HRMS (APCI/[M+H]+) 




1-(4-methoxyphenyl)hept-2-yn-1-one (6a): Derived from 4-methoxybenzoyl chloride 
(17.1 mg, 0.10 mmol, 1.0 equiv.), potassium trifluoro(hex-1-yn-1-yl)borate (1e) (47.0 mg, 
0.25 mmol, 2.5 equiv.) and boron trichloride (29.3  mg, 0.25 mmol, 2.5 equiv.) in 0.5 mL 
of DCM.  Purification by silica gel column chromatography using hexanes/EtOAc (15/1) 
and pentane wash afforded the product 6a (9.3 mg, 43%) as a yellow oil. IR (film) ν 2205, 
1637, 1596, 1256, 1166, 1029, 845, 758, 687 cm-1; 1H NMR (CDCl3) δ8.10 (dt, J = 8.0, 2.5 
Hz, 2H), 6.94 (dt, J = 8.5, 3.0 Hz, 2H), 3.88 (s, 3H), 2.49 (t, J = 7.0, 2H), 1.66 (quin, J = 8.0 
Hz, 2H), 1.51 (m, 2H), 0.96 (t, J = 7.5, 3H); 13C {1H} NMR (CDCl3) δ 176.9, 164.2, 131.9, 
130.4, 113.7, 95.9, 79.6, 55.5, 29.9, 22.1, 18.9, 13.5; HRMS (ESI/[M+H]+) calcd. for 
C14H16O2 217.1223, found 217.1213. 
 
 
Acetic 2,4,6-trimethoxybenzoic anhydride (7a): Derived from 2,4,6-trimethoxybenzoic 
acid and acetyl chloride. 7a was obtained in 66% yield as a tan, crystalline solid. IR (film) ν 
1734, 1690, 1597, 1251, 1127, 804, 633 cm-1; 1H NMR (400MHz, CDCl3) δ 6.10(s, 2H), 
3.84(s, 3H), 3.84(s, 6H), 2.26(s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ 166.7, 164.0, 160.5, 






Acetic 2,6-dimethoxybenzoic anhydride (7b): Derived from 2,6-dimethoxybenzoic acid 
and acetyl chloride. 7b was obtained in 79% yield as a pale yellow, crystalline solid. IR 
(film) ν 1755, 1588, 1475, 1257, 1108, 981 cm-1; 1H NMR (400MHz, CDCl3) δ 7.35 (t, J = 8.2 
Hz, 1H), 6.58 (d, J = 8.2 Hz), 3.85 (s, 6H), 2.30 (s, 3H). HRMS (ESI/[M+Na]+) calcd. for 




Prepared from trifluoroborate 1c and anhydride 7a. Ynone 8a was eluted from the column 
with hexanes-EtOAc (1:4) and obtained in 49% yield as a brown, crystalline solid. IR (film) 
ν 2922, 2851, 2190, 1603, 1548, 1249, 1216, 829, 797 cm-1; 1H NMR (400MHz, CDCl3) δ 
13.68 (s, 1H), 7.59 (dt, J = 9.0, 2.3 Hz, 2H), 6.93 (dt, J = 9.0, 2.0 Hz, 2H), 6.08 (d, J = 2.3 Hz, 
1H), 5.96 (d, J = 2.3 Hz, 1H), 3.94 (s, 3H), 3.87 (s, 3H), 3.85 (s, 3H); 13C {1H} NMR (CDCl3) δ 
177.6, 168.2, 167.1, 162.6, 161.5, 135.0, 114.4, 113.0, 110.0, 96.1, 93.5, 91.0, 89.7,  55.8, 







1-(2-hydroxy-4,6-dimethoxyphenyl)-3-phenylprop-2-yn-1-one (8b): Prepared from 
trifluoroborate 1a and anhydride 7a. Ynone 8b was eluted from the column with hexanes-
EtOAc (1:4) and obtained in 71% yield as a yellow solid. IR (film) ν 2991, 2851, 2205, 1614, 
1573, 1345, 1293, 1220, 1152, 832, 803, 690, 611 cm-1; 1H NMR (400MHz, CDCl3) δ 13.58 
(s, 1H), 7.64 (dt, J = 7.0, 1.6 Hz, 2H), 7.43 (m, 3H), 6.09 (d, J = 2.3 Hz, 1H), 5.96 (d, J = 2.3 
Hz, 1H), 3.94 (s, 3H), 3.86 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ 177.6, 168.3, 167.4, 
162.7, 132.9, 130.4, 128.59, 121.2, 107.1, 94.8, 93.5, 91.1, 89.7, 55.8, 55.7. HRMS 
(ESI/[M+H]+) calcd. for C17H15O4 283.0965, found 283.0968. 
 
 
1-(2-hydroxy-6-methoxyphenyl)-3-phenylprop-2-yn-1-one (8c): Prepared from 
trifluoroborate 1a and anhydride 7b. Ynone 8c was eluted from the column with hexanes-
EtOAc (1:7) and obtained in 63% yield as a yellow solid. This compound has been reported 
in the literature.[34g] IR (film) ν 2922, 2852, 2197, 1616, 1580, 1454, 1359, 1239, 1087, 800, 
744, 683 cm-1; 1H NMR (400MHz, CDCl3) δ12.81 (s, 1H), 7.65 (dt, J = 6.6, 1.6 Hz, 2H), 7.44 
(m, 3H), 6.59 (dd, J = 8.4, 1.0 Hz, 1H), 6.43 (d, J = 8.2 Hz, 1H), 3.98 (s, 3H); 13C {1H} NMR 
(CDCl3, 100MHz) δ 179.6, 165.2, 161.4, 137.5, 133.1, 130.7, 128.7, 120.9, 112.1, 110.5, 





1-(2-hydroxy-6-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-yn-1-one (8d): Prepared 
from trifluoroborate 1b and anhydride 7b. Ynone 8d was eluted from the column with 
hexanes-EtOAc (1:5) and obtained in 76% yield as a yellow solid. IR (film) ν 2932, 2838, 
2184, 1601, 1553, 1447, 1365, 1239, 1163, 1083, 1029, 822 cm-1; 1H NMR (400MHz, CDCl3) 
δ12.91 (s, 1H), 7.61 (dt, J = 9.0, 2.3 Hz, 2H), 7.40 (t, J = 8.2 Hz, 1H), 6.94 (dt, J = 8.6, 2.7 Hz, 
2H) 6.59 (dd, J = 8.6, 0.8 Hz, 1H), 6.43 (dd, J = 8.2, 0.8 Hz, 1H), 3.99 (s, 3H), 3.87 (s, 3H); 13C 
{1H} NMR (CDCl3, 100MHz) δ 179.5, 165.2, 161.7, 161.3, 137.2, 135.3, 114.4, 112.7, 
112.07, 110.6, 101.4, 96.9, 90.2, 55.9, 55.5. HRMS (ESI/[M+H]+) calcd. for C17H15O4 
283.0965, found 283.0968. 
 
 
1-(2-hydroxy-6-methoxyphenyl)-3-(naphthalen-1-yl)prop-2-yn-1-one (8e): Prepared 
from trifluoroborate 1f  and anhydride 7b. Ynone 8e was eluted from the column with 
hexanes-EtOAc (1:15) and obtained in 65% yield as a yellow solid. IR (film) ν 2921, 2852, 
2175, 1619, 1586, 1543, 1454, 1357, 1243, 1222, 1088, 797, 771, 685, 628 cm-1; 1H NMR 
(400MHz, CDCl3) δ 12.89 (s, 1H), 8.51 (d, J = 7.8 Hz, 1H), 7.99 (d, J = 8.2 Hz, 1H), 7.92 (m, 
2H), 7.65 (m, 1H), 7.59 (m, 1H), 7.53 (m, 1H), 7.44 (t, J = 8.4 Hz, 1H), 4.00 (s, 3H); 13C {1H} 
NMR (CDCl3, 100MHz) δ 179.5, 165.3, 161.4, 137.5, 133.8, 133.1, 131.3, 128.5, 127.5, 
126.9, 126.0, 125.3, 118.5, 112.1, 110.7, 101.5, 94.8, 93.9, 55.9. HRMS (ESI/[M+H]+) calcd. 




3-(3-fluorophenyl)-1-(2-hydroxy-6-methoxyphenyl)prop-2-yn-1-one (8f): Prepared from 
trifluoroborate 1g  and anhydride 7b. Ynone 8f was eluted from the column with hexanes-
EtOAc (1:15) and obtained in 35% yield as a yellow solid. IR (film) ν 2923, 2841, 2200, 
1617, 1575, 1544, 1457, 1360, 1224, 1091, 1027, 747, 674 cm-1; 1H NMR (400MHz, CDCl3) 
δ12.71 (s, 1H), 7.42 (m, 3H), 7.32 (m, 1H), 7.19 (m, 1H), 6.60 (d, J = 9.4, 1H), 6.43 (d, J = 
9.4, 1H), 3.97 (s, 1H); 13C {1H} NMR (CDCl3, 100MHz) δ179.3, 165.2, 163.5, 161.4, 137.7, 
130.3 (d, J = 9.0 Hz, 1C), 128.9, 122.8, 122.7, 119.6 (d, J = 22 Hz, 1C), 118.0 (d, J = 22 Hz, 




5-methoxyflavone/5-methoxy-2-phenyl-4H-chromen-4-one (9a): Derived from o-
alkynoylphenol 8c. Flavone 9a was eluted from the column with methanol-DCM (1:24) 
and obtained in 76% yield as a pale yellow solid. This compound has been reported in the 
literature. [34g] IR (film) ν 2921, 2852, 1644, 1598, 1475, 1379, 1261, 1095, 743 cm-1; 1H 
NMR (400MHz, CDCl3) δ 7.90 (m, 2H), 7.58 (t, J = 8.2 Hz, 1H), 7.52(m, 3H), 7.15 (dd, J = 8.4, 
1.0 Hz, 1H), 6.84 (d, J = 7.8 Hz, 1H), 6.75(s, 1H), 4.01 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) 






5,7-dimethoxyflavone/5,7-dimethoxy-2-phenyl-4H-chromen-4-one (9b): Derived from 
o-alkynoylphenol 8b. Flavone 9b was eluted from the column with methanol-DCM (1:19) 
and obtained in 97% yield as a pale yellow solid. This compound has been reported in the 
literature.[85] IR (film) ν 2922, 2851, 1646, 1604, 1347, 1160, 1120, 819, 723 cm-1; 1H NMR 
(400MHz, CDCl3) δ 7.89 (m, 2H), 7.51 (m, 3H) 6.69(s, 1H), 6.59(d, J = 2.3Hz, 1H), 6.39(d, J 
= 2.3Hz, 1H), 3.97 (s, 3H), 3.92 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ177.6, 164.0, 160.9, 




Derived from o-alkynoylphenol 8d. Flavone 9c was eluted from the column with 
methanol-DCM (1:24) and obtained in 51% yield as a tan solid. This compound has been 
reported in the literature.[86] IR (film) ν 2922, 2843, 1645, 1599, 1473, 1258, 1093, 826, 
610 cm-1; 1H NMR (400MHz, CDCl3) δ 7.85 (dt, J = 9.0, 2.3 Hz, 2H), 7.56 (t, J = 8.4 Hz, 1H), 
7.13 (dd, J = 8.2, 0.8 Hz, 1H), 7.01 (dt, J = 9.0, 2.3 Hz, 2H), 6.83 (d, J = 8.2 Hz, 1H), 6.67(s, 
1H), 4.00 (s, 3H), 3.89 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ178.4, 162.2, 161.2, 159.8, 






Derived from o-alkynoylphenol 8a. Flavone 9d was eluted from the column with 
methanol-DCM (1:24) and obtained in 55% yield as a light brown solid. This compound 
has been reported in the literature.[85] IR (film) ν 2924, 2839, 1635, 1598, 1342, 1246, 
1157, 1110, 828 cm-1; 1H NMR (400MHz, CDCl3) δ 7.82 (dt, J = 9.0, 2.0 Hz, 2H), 7.00 (dt, J 
= 9.0, 2.7 Hz, 2H) 6.60(s, 1H), 6.56(d, J = 2.3Hz, 1H), 6.38(d, J = 2.3Hz, 1H), 3.96 (s, 3H), 
3.92 (s, 3H), 3.88 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ 177.7, 163.9, 162.1, 160.9, 160.8, 
159.8, 127.6, 123.8, 114.3, 109.2, 107.6, 96.1, 92.8, 56.4, 55.7, 55.5.  
 
 
5-methoxy-2-(naphthalen-1-yl)-4H-chromen-4-one (9e): Derived from o-alkynoylphenol 
8e. Flavone 9e was eluted from the column with methanol-DCM (1:20) and obtained in 
obtained in 32% yield as a dark brown oil. IR (film) ν 2925, 2840, 1639, 1602, 1472, 1371, 
1080, 725 cm-1; 1H NMR (400MHz, CDCl3) δ 8.16 (m, 1H), 8.02 (d, J = 8.2 Hz, 1H), 7.77 (dd, 
J = 7.0, 1.2 Hz, 1H), 7.59 (m, 4H), 7.10 (m, 1H), 6.89 (d, 1H), 6.61 (s, 1H), 4.05 (s, 3H); C {1H} 
NMR (CDCl3, 100MHz) δ 178.1, 163.1, 160.0, 158.8, 133.8, 133.7, 131.4, 130.4, 128.7, 
127.9, 127.3, 126.5, 125.0, 124.9, 114.7, 114.6, 110.3, 110.0, 106.6, 56.6. HRMS 






Derived from o-alkynoylphenol 8c. Aurone 10a was obtained in 95% yield as a yellow, 
crystalline solid. IR (film) ν 2924, 2845, 1704, 1654, 1594, 1491, 1250, 1072, 796, 751, 686 
cm-1; 1H NMR (400MHz, CDCl3) δ 7.91 (m, 2H), 7.58(t, J = 8.2 Hz, 1H), 7.46 (tt, J = 7.3, 1.2 
Hz, 2H), 7.39 (tt, J = 7.4, 1.2 Hz, 1H), 6.90 (d, J = 8.2 Hz, 1H),  6.85 (s, 1H), 6.63 (d, J = 8.6 
Hz, 1H), 4.02(s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ182.4, 167.1, 158.6, 146.9, 138.4, 
132.5, 131.3, 129.6, 128.8, 111.9, 110.9, 105.2, 104.8, 56.3. HRMS (ESI/[M+H]+) calcd. for 




(10b): Derived from o-alkynoylphenol 8b. Aurone 10b was obtained in 88% yield as a 
yellow, crystalline solid. This compound has been reported in the literature.[87] IR (film) ν 
2922, 2844, 1693, 1583, 1206, 1150, 1090, 809, 691 cm-1; 1H NMR (400MHz, CDCl3) δ 7.87 
(d, J = 7.0 Hz, 2H), 7.44(t, J = 7.4 Hz, 2H), 7.38 (m, 1H), 6.77 (s, 1H), 6.40 (d, J = 1.6 Hz, 1H), 
6.14 (d, J = 1.6 Hz, 1H), 3.96(s, 3H), 3.92 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ180.7, 






one (10c): Derived from o-alkynoylphenol 8d. Aurone 10c was obtained in 99% yield as an 
orange, crystalline solid. IR (film) ν 2922, 2851, 1697, 1651, 1592, 1494, 1246, 1070, 825, 
793, 759 cm-1; 1H NMR (400MHz, CDCl3) δ 7.87 (dt, J = 8.6, 2.3 Hz, 2H),  7.56(t, J = 8.2 Hz, 
1H), 6.98 (dt, J = 9.0, 3.1 Hz, 2H), 6.88 (d, J = 8.2 Hz, 1H),  6.83 (s, 1H), 6.61 (d, J = 8.2 Hz, 
1H), 4.01 (s, 3H), 3.87 (s, 3H); 13C {1H} NMR (CDCl3, 100MHz) δ 182.2, 166.8, 160.8, 158.5, 
145.8, 138.0, 133.1, 125.2, 114.4, 112.2, 111.1, 104.9, 104.7, 56.2, 55.3. HRMS 
(ESI/[M+H]+) calcd. for C17H15O4 283.0965, found 283.0965. 
 
(Z)-4’,4,6-trimethoxyaurone/(Z)-4,6-dimethoxy-2-(4-methoxybenzylidene)benzofuran-
3(2H)-one (10d): Derived from o-alkynoylphenol 8a. Aurone 10d was obtained in 99% 
yield as a dark yellow, crystalline solid. This compound has been reported in the 
literature.[88] IR (film) ν 2922, 2849, 1688, 1588, 1507, 1246, 1206, 1150, 1086, 818 cm-1; 
1H NMR (400MHz, CDCl3) δ 7.84 (dt, J = 9.0, 2.3 Hz, 2H), 6.97 (dt, J = 9.0, 2.3 Hz, 2H), 6.77 
(s, 1H), 6.40 (d, J = 2.0 Hz, 1H), 6.15 (d, J = 2.0 Hz, 1H), 3.97(s, 3H), 3.93 (s, 3H), 3.87 (s, 
3H); 1H NMR (400MHz, CDCl3) δ 7.87 (d, J = 7.0 Hz, 2H), 7.44(t, J = 7.4 Hz, 2H), 7.38 (m, 
1H), 6.77 (s, 1H), 6.40 (d, J = 1.6 Hz, 1H), 6.14 (d, J = 1.6 Hz, 1H), 3.96(s, 3H), 3.92 (s, 3H); 
13C {1H} NMR (CDCl3, 100MHz) δ 180.64, 168.7, 160.6, 159.4, 146.8, 132.9, 125.3, 114.3, 





3(2H)-one (10e): Derived from o-alkynoylphenol 8f. 10e was obtained in 78% yield as a 
yellow, crystalline solid. IR (film) ν 2918, 2846, 1704, 1651, 1600, 1493, 1442, 1243, 1074, 
794, 753, 679 cm-1; 1H NMR (400MHz, CDCl3) δ 7.71 (m, 1H), 7.60 (m, 2H), 7.41 (m, 1H), 
7.09 (m, 1H), 6.91 (d, J = 8.2 Hz, 1H), 6.79 (s, 1H), 6.65 (d, J = 8.2 Hz, 1H), 4.02 (s, 3H); 13C 
{1H} NMR (CDCl3, 100MHz) δ 182.3, 167.1, 164.1, 161.6, 158.6, 147.4, 138.7, 134.5, 130.2 
(d, J = 8.0 Hz, 1C), 127.2, 117.4 (d, J = 22.0 Hz, 1C), 116.5 (d, J = 21.0 Hz, 1C), 110.3, 105.4, 




methoxyphenyl)prop-2-yn-1-one (15): 15 was obtained in 16% yield as a yellow solid. 1H 
NMR (400MHz, CDCl3) δ 13.01 (s, 1H), 7.54 (d, J = 8.6 Hz, 2H), 6.90 (d, J = 8.6 Hz, 2H), 
6.03 (dd, J = 60.0, 4.0 Hz, 2H), 3.85 (s, 3H), 3.82 (s, 3H), 0.96 (s, 6H), 0.26 (s, 9H); 13C {1H} 
NMR (CDCl3, 100MHz) δ 178.6, 167.0, 166.5, 161.1, 159.4, 134.4, 114.2, 113.1, 109.8, 
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